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ABSTRACT OF THESIS submitted by Ross Morgan 
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Image-Based Modelling of the Electrophysiological and Structural Effects of Fibrosis 
on the Mechanics of Atrial Fibrillation 
April 2016 
Atrial fibrillation (AF) is a degenerative cardiac arrhythmia characterised by high 
incidence rate and limited effectiveness of clinical treatments. Fibrosis is one of the 
major pathological factors linked with AF progression. However, mechanistic links 
between this pathology and AF arrhythmogenesis are incompletely understood. 
This project investigates the diverse arrhythmogenic effects of fibrosis using 
computational model of the human atria, which integrates electrophysiological and 
structural changes associated with fibrosis. Structural data is reconstructed based 
on magnetic resonance imaging (MRI) from AF patients. 
The computational model of the 3D human atria integrated the Visible Female 
cardiac geometry, rule-based fibre orientation, region-specific atrial 
electrophysiology and its changes due to AF-induced ionic remodelling. Fibrosis was 
modelled by integrating (i) a novel electrophysiologically detailed model for a single 
atrial fibroblast, (ii) electrotonic myocyte-fibroblast (M-F) coupling, (iii) structural 
effects of fibrosis on the anisotropy of atrial tissue and (iv) either random or 
patient-specific distributions of fibrosis in the 3D atrial model. Patient-specific 
distributions were reconstructed from late-gadolinium enhanced (LGE) MRI.  
At the single-cell level, electrotonic M-F coupling via gap junctions resulted in 
changes of the atrial myocyte electrophysiological properties, including the resting 
membrane potential, action potential duration (APD) and its restitution, regional 
APD heterogeneity, effective refractory period and cell excitation threshold. At the 
3D atria level, these changes translated into the altered susceptibility for atrial re-
entry. Additional changes of the tissue anisotropy and heterogeneity, both 
associated with non-uniform fibrosis in the atria, resulted in the breakdown of re-
entry into multiple rotors and wavelets, which is characteristic of AF.  
Application of LGE MRI enabled the segmentation of patchy fibrosis from AF 
patients. An image processing and modelling pipeline was developed to maps the 
distributions of fibrosis into the 3D atrial model and investigate the effects of 
regional fibrosis patches on the genesis of AF. Simulations the patient-specific 
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model revealed pinning of re-entrant waves primarily at the border zone of dense 
fibrosis patches. Patient-specific atrial wall thickness was also reconstructed using 
novel PSIR MRI protocol and integrated into the 3D model. This non-uniform 
structural feature provided additional locations for the wave pinning in regions of 
minimum atrial wall thickness.  
In summary, the developed MRI processing and computational modelling pipeline 
has been applied for dissecting the multiple effects of fibrosis in the genesis of AF. 
Novel insights provided by the image-based models pave a way for understanding 
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Atrial fibrillation (AF) is a common degenerative cardiac arrhythmia. The incidence 
rate of this condition is high, however current clinical treatments have limited 
effectiveness. It develops in the atria and produces an irregular heart rate, reducing 
the cardiac output of the organ. Although the condition is largely confined to the 
upper chambers of the heart and may be relatively benign, it is known to lead to 
severe complications such as stroke or congestive heart failure. The patient 
suffering from AF also has reduced quality of life due to the lower cardiac output 
which can cause fatigue and requires long-term medication.  
The progression of the disease is such that up to 24% of paroxysmal patients will 
progress to persistent AF1 and 31% will progress to permanent AF2. This process is 
self-sustaining, as described by the idiom "AF begets AF". A further complication is 
that treatments become less effective as the duration of AF increases.1 A definitive 
cause for the disease progression is unknown, but various functional and structural 
factors have been associated with arrhythmogenesis.  
The risk of stroke in AF patients is 5 times greater than non-sufferers.3 Due to the 
lack of organised atrial contraction, blood can stagnate within the atria, and lead to 
thrombus formation. Over a quarter of patients diagnosed with AF also have 
congestive heart failure (CHF), with 16% of AF diagnoses developing CHF later in 
life4. The co-morbidity of these conditions leads to greatly increased risks of 
cardiovascular events and fatalities.5 The lifetime risk of developing the disorder 
after the age of 40 is 26% for men, and 23% for women6 with global prevalence in 
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2010 being 33.5 million7.  With a globally aging population and continued 
improvements to life expectancies, this number will continue to grow.  
Existing treatments have varied and limited levels of success which leads to high 
rates of recurrence. Treatments such as, front-line anti-arrhythmic drug therapy 
and emerging catheter ablation are characterised by ~30-50% recurrence. This 
shows that a better understanding of the disorder is required for the development 
of more effective treatments. Due to the complexity of AF and a large number of 
underlying structural and electrophysiological factors, a single definitive cause has 
not yet been identified. The limitations of current in-vivo electrophysiology 
recording methods are a major hindrance for experimental AF studies. 
Biomedical engineering is increasingly relying on computational modelling in order 
to investigate the physiological and pathological factors that contribute to 
cardiovascular disease, including AF arrhythmogenesis. Modelling allows in-silico 
simulation of atrial electrophysiology and non-invasive dissection of the complex 
cell-to-organ factors underlying the development and progression of AF.  
1.1. Aims of the thesis 
Atrial fibrosis is one of the major pathological factors associated with AF 
progression. There is a strong correlation between AF duration and increased atrial 
fibrosis, which has been used for AF condition stratification. This form of structural 
remodelling leads to increasing collagen deposits within the tissue and it has been 
hypothesised that fibrotic invasion of the myocardium has arrhythmogenic effects. 
Moreover, ablation of fibrotic areas identified from clinical imaging or electro-
anatomical mapping can significantly improve the ablation therapy success rates8,9. 
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However, due to the difficulty in matching the recordings of AF patient 
electrophysiology with the underlying tissue structure, this has not yet been 
supported with solid evidence.  
The aim of this thesis is to develop a computational model to investigate the effects 
of fibrosis on the generation and sustenance of AF. To accomplish this goal, a multi-
scale 3D whole-atria model was created to integrate several state-of-the-art 
elements developed in collaboration with leading groups. The model includes 
human image-based atrial structure and established cell electrophysiology models.  
Individual aims for each chapter have been identified to investigate the overall 
effects of fibrosis and atrial structure: 
1. Investigate the effects of myocyte-fibroblast coupling in single cell 
simulations, 
2. Investigate the 3D effects of homogenous fibrosis, 
3. Investigate patient specific aspects of fibrosis, 
4. Investigate the variations and effects of atrial wall thickness on 
arrhythmogenesis. 
The modelling results will be used to provide a mechanistic explanation for the 
success of ablation around fibrotic areas. 
1.2. Thesis overview 
The thesis is divided by topic of investigation; an overview of the structure of the 
thesis is detailed below.  
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Chapter 2 introduces the problems faced in AF research and gives background 
information, from basic cardiac anatomy to mathematical modelling techniques, 
and outlines the methods used for the modelling, imaging and image processing. 
Chapter 3 provides details of the development of single cell models, including a 
single atrial fibroblast model and the myocyte-fibroblast coupling model. This 
chapter also explores the dynamic effects of these models, such as the effects of 
fibroblasts on myocyte electrophysiology. 
Chapter 4 describes the investigation into the 3D dynamics of the human atrial 
model. Specifically, it looks into the electrophysiological effects of uniform diffuse 
fibrosis within 3D atrial tissue. In addition the investigation of the effect of fibrosis-
related tissue anisotropy on arrhythmogenesis is also described. 
Chapter 5 describes the investigation into patient-specific fibrosis. The image 
processing pipeline is described, which was developed to process late gadolinium 
enhanced MRI into a volumetric dataset compatible with the 3D atrial model. This 
chapter concludes with the in-silico findings of the 3D re-entrant wave dynamics in 
heterogeneous fibrosis distributions.  
Chapter 6 details the investigation into atrial wall thickness reconstructed from 
novel MRI data and its additional effects on AF arrhythmogenesis. Atrial wall 
thicknesses were measured from both AF patients and volunteers, and an atlas of 
volunteer thicknesses was created. Simulations using the reconstructed 3D atrial 




Chapter 7 provides an overview of the whole thesis, linking the conclusions for each 





2. Background  
2.1. Cardiac anatomy 
The heart is the primary mechanical driver for the human cardiovascular system. It 
is responsible for driving the transport of blood, containing oxygen and nutrients to 
and from all tissues in the body. The organ comprises of four chambers (Figure 1).  
 
Figure 1. Illustration of cardiac anatomy. A. Right ventricle, B. Left ventricle, C. Right atrium, 
D. Left atrium, E. Aortic Arch, F. Pulmonary trunk, G-J. Carotid arteries, K. Superior Vena 




The two lower and larger chambers, the ventricles, provide the muscular 
contraction as the driving force for blood circulation. The atria are the two smaller 
superior chambers of the heart. The walls of the atria are much thinner (1-5mm) 
than the ventricles (11mm) due to lower mechanical workload. They also have no 
valves on the inflow vessels and therefore have a lower pressure capacity. The four 
chamber structure of the heart enables the separation of the pulmonary from the 
systemic circulation systems. This partitions the oxygenated blood and the de-
oxygenated blood within the heart.  
The left atrium (LA) is supplied with blood by the pulmonary veins (PV), the most 
common configuration of the veins is two entering on both the left and right sides. 
The chamber empties into the left ventricle (LV) via the mitral valve. The right 
atrium (RA) is supplied by the superior and inferior vena cava (SVC and IVC) and fills 
the right ventricle (RV) via the tricuspid valve. 
The atria have several unique anatomical structures (Figure 2), which directly 
influence their functional and electrophysiological properties. Examples include the 
sinoatrial node (SAN) which generates the stimulus for cardiac contraction to the 
atrial septum (AS) which separates the blood volumes of the atria.  
The atrial appendages in the LA and RA (LAA and RAA respectively) extend beyond 
the atria and over their respective ventricles. These chambers contain high density 
networks of pectinate muscles (PM), which are large muscle fibre bundles. The 
function of the appendages is disputed but it has been suggested that they increase 
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chamber volume prior to ventricular filling or act as a decompression chamber for 
periods of atrial hypertension10.  
The two atria are separated by the AS which prevents blood transfer between the 
atria, except in the foetus, where transfer is permitted through a leaflet opening 
known as the foramen ovale. At birth the decrease in pulmonary circulation 
pressure permanently closes the foramen ovale. The septum has a bilaminar 
muscular structure separated by connective tissue,11 which reduces 
electrophysiological conduction across the structure and between atria. 
The SAN is difficult to identify by observation due to its small size and macroscopic 
similarity to the surrounding myocardium. It can be identified histologically by the 
finer and more irregular fibre structure or by the presence of proteins responsible 
for its pacemaking function. The SAN is comprised of autonomously activating 
myocardial cells, moderated by the adrenergic and vagal nerves. It is responsible for 
initiating the electrophysiological waves that cause the organ to contract.  
Several fibrous bundles facilitate trans-septal conduction between the atria. The 
largest of these is the Bachmann’s bundle (BB). It runs from the top of the RA into 
the anterior tissue of the LA, the origin of the BB is located close to the SAN 
providing rapid progression of the wave into the LA. The coronary sinus (which is a 
coronary vein) and other smaller posterior septal conduction pathways have also 
been shown to promote trans-septal conduction12. 
The crista terminalis (CT) is a large fibrous bundle that is the junction between the 
right atrium and the right atrial appendage. It runs from the SVC to the IVC. As with 
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the BB, the CT accelerates conduction along the bundle. This increases the speed of 
wave propagation from the SAN (which is located at superior end of the CT) 
towards the ventricles.  
Figure 2. Atrial structures and features. A is a schematic diagram of a coronal dissection 
through both atria. The main structures of the LA are the PV (1), the mitral valve (2), the 
LAA and the AV node (3). The main structures of the RA are the SVC and IVC (4,5), the 
tricuspid valve (6), RAA, CT (7) and SAN (8). Some structures are shared between the atria, 
and control conduction pathways: the atrial septum (9) which electrically separates the 
atria and the BB (10), a fibrous tissue which facilitates controlled inter-atrial conduction. B 
shows a lateral dissection through both atria and is sourced from Ho et al.13 
The tissue of all cardiac chambers is comprised of striated muscle and is relatively 
homogeneous in terms of cell diversity, with the main cell mass comprising of 
myocytes.  Myocytes (Figure 3) provide the mechanical force for all muscular tissue. 
They are elongated, tubular cells and contain longitudinal myofibrils which allow 
the cell to contract. Unlike skeletal myocytes, cardiac myocytes have a single 
nucleus. The cells are connected end to end via intercalcated disks (ICD) which 
contribute to tissue synchrony by allowing ionic transfer between cells and act as 
anchoring points for myofibrils. The structure of bundles of fibres is optimal for 













Figure 3. Illustration of the structure of atrial tissue using histology. The image is a 
trichrome stained histological slide of atrial myocardium. It shows the fibrous structure of 
the tissue and parts of the cell including the inter-calated disks (ICD) the nucleus (N) and 
fibrosis (F, stained in blue). A whole myocyte length of approximately 100 μm is indicated by 
the line M (myocytes are stained in red). Image reproduced with permission from 
WebPath(R)14 
Although the main function of the cell is to provide mechanical force for tissue 
contraction, the cell also acts as an electrical signal transceiver. This function is 
explored in more detail throughout the following section along with the facilitation 
of anisotropic conduction.   
2.2. Atrial function 
The main mechanical function of the atria is to facilitate the passage of blood to the 
ventricles uni-directionally via the atrio-ventricular (AV) valves. The stages of this 
process have passive (conduit phase) and active (booster pump phase) phases as 
well as an inactive filling (reservoir) stage.  The atria also allow for the generation 







waves originate in the SAN and initiate contraction of the cells as they pass through 
atrial and then ventricular tissues, regulating the contraction order of the heart 
chambers. 
In sinus rhythm, the conduction of the electrical waves through the tissue must 
follow a regimented route. The electrical signal (action potential) is initiated in the 
RA by autonomously activating cells of the SAN. The wave then propagates across 
the RA aided by fast conduction along the CT and pectinate muscles, resulting in 
their contraction. Accelerated trans-septal conduction is promoted through the BB. 
The wave passes through the LA from top to bottom, ensuring its contraction after 
the RA. Simultaneously, propagation in the RA has reached the inferior wall and the 
AV node, which promotes conduction into the ventricles via the bundle of Hiss.  
Figure 4. Atrial action potentials and traces of underlying ionic channel currents. The top 
plot shows a membrane voltage trace of two action potentials marking phases 1-4 as well 














The excitation waves responsible for initiating the heart contractions are sustained 
by a cascade of action potentials generated in each cardiac cell. Due to the 
capacitive properties of the cell membrane and ionic concentrations gradients 
across the membrane, myocytes can maintain a resting potential across the 
membrane. Through a series of voltage-dependent opening and closing of specific 
ionic channels in the membrane and the subsequent fluxes of ions across the 
membrane, the cells can create a “voltage spike” known as an action potential (AP). 
The ionic fluxes are driven by the potential and concentrations gradients across the 
membrane, whereas the voltage-dependence of ionic channels is based on 
conformational changes of the channel-forming proteins.  
The major ionic channel currents seen in Figure 4B are activated in a specific 
sequence to generate a cardiac AP (Figure 4A). This differs from a neuronal AP by 
the plateau phase (phase 2), which gives cardiac AP a longer duration. This allows 
for a larger influx of calcium at this phase which activates the myofibrils, facilitating 
cellular contraction.    
Phase 0 (depolarisation). The sodium current drives sodium ions into the cell, which 
rapidly increases the membrane potential.  The sodium activation gate opens when 
a threshold membrane potential is exceeded, due to current flowing into the cell, 





Table 1. Description of main ion channel currents responsible for the consecutive AP phases. 
Phase 1 (early repolarisation), as the sodium channels close, the transient outward current 
(Ito) activates causing a rapid repolarisation and the characteristic ("notch") in membrane 
potential.  
Phase 2 (plateau) is determined by L-type calcium channels opening and Ca2+ ions 
entering the cell, which prevents the cell being immediately repolarised. During this 
period the cell physically contracts as the calcium ions initiate the contraction of the 
microfilaments. During this phase the major currents are in quasi-equilibrium, with 
calcium (inward) and potassium (outward) balancing each other and resulting in 
























INa In Fast sodium current: Rapid depolarisation 
current that initiates the AP 
0 NaV1.5 
Ito Out Transient outward current: Response to 
depolarisation, begins to repolarise cell. 
1 Kv4.3 
ICl In Chloride current: Response to depolarisation, 
similar action to Ito 
1  
IKur Out Ultra-rapid potassium current: Response to 
depolarisation, begins to repolarise cell 
1/2 Kv1.5 
ICaL In L-type calcium current: Sustains the long AP 
plateau, responsible for contraction 
2 Cav1.2 
IKs Out Slow potassium current: Acts to repolarise the 
membrane later during the plateau 
2/3 Kv7.1 
IKr Out Rapid potassium current: Acts to repolarise 




Inward rectifier potassium current: 




IKACh Out Acetylcholine-activated potassium current: 
Repolarising current and only active in the 





Phase 3, when the Ca2+ channels are closed, the net current is dominated by K+ 
outflow from the cell, which starts to repolarise the cell and ultimately restores the 
resting potential (Phase 4). 
The propagation of the AP waves through the tissue is permitted by the gap 
junctions, which are non-specific ionic channels present in the intercalated disks at 
the junction between cells. The gap junctions allow connected cells to exchange 
ionic charge and change the membrane potential; once a cell reaches a threshold 
potential, the sodium channel will activate and the AP will be triggered.  
Abnormalities of AP generation at the single cell level are considered pro-
arrhythmogenic. There are two main types of abnormal impulse, which are defined 
by the time they are activated within the action potential. Early after 
depolarisations (EADs) are activated during phases 2-3 and are more likely to occur 
when the action potential duration is longer.  Delayed after- depolarisations (DADs) 
occur in late phase 3 or phase 4, when the cells are predominantly depolarised. 
Both EADs and DADs can act as initial triggers of abnormal waves leading to AF.  
At the tissue level, the overall wave dynamics can be significantly affected by 
minimum reactivation time, known as the effective refractory period (ERP). The ERP 
effectively defines the wavelength of the propagating wave which is a determining 
factor in the generation of fibrillatory re-entrant circuits (see section 2.3 below). 
Wavelength (WL) isn’t wholly defined by the ERP, but is a product of ERP and the 
conduction velocity (CV) (equation 1).   
𝑊𝐿 = 𝐶𝑉 × 𝐸𝑅𝑃        ( 1 ) 
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The latter, in turn is dependent on the number of active gap junctions between the 
cells, the proximity of cells and the viability of the tissue. In sinus rhythm, the 
wavelength of propagating waves is sufficiently long (17cm16) that the atria can only 
accommodate a single wave (the average longitudinal diameter of the LA is 
5.7cm17), effectively preventing re-entry of the wave. Therefore, structural or 
electrophysiological changes are required in order for AF to occur.  
 
Figure 5. Recurrence rates of AF after treatments. Standard anti-arrhythmic drug 
(Sotalol/Propafenone) treatment has a long-term success rate of only about 40%. Although 
Amiodarone shows a higher effectiveness, it is toxic to the patient18, limiting its longterm 
application. B. The follow up of a single ablation attempt has a minimum arrhythmia free 
survival of 30% (at 5 years). C. The follow up of arrhythmia free survival after multiple 
ablations, which increases to 65% at 5 years. Images from Weerasooriya et al.19  
A 
  
                      
B              C            
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2.3. Atrial Fibrillation 
AF is the most common sustained cardiac arrhythmia6 with an incidence of 2.66 
million cases in the US in 2010. Although the arrhythmia may be relatively benign, 
the condition is known to lead to severe complications such as stroke or congestive 
heart failure. AF is often chronic and progressive, exhibiting a self-sustained and 
treatment-resistant nature. The aging population is a major contributing factor for 
the recent increase in AF incidence. AF is characterised by rapid and chaotic 
electrophysiological activation of the atrial tissue and is distinct from atrial flutter 
by its higher and more irregular frequency.  
2.3.1. Current treatments  
Current treatments for AF are limited, have low success rates and high rates of 
reoccurrence. There are currently three main therapeutic options for patients 
diagnosed with AF: drug therapies, cardioversion and catheter ablation. 
Ablation therapy is used to block conduction in certain areas to in order to prevent 
AF stabilisation. The pulmonary veins have been identified empirically as sources of 
electrical activity sustaining AF and are most commonly used as a target for 
ablation20.  The pulmonary veins are electrically isolated to prevent electrical 
interaction with the rest of the atria. The isolation is accomplished using a high 
energy radiofrequency (RF) catheter to cauterise the endocardial surface of the 
atria. The resulting thermal damage of the tissue leads to the creation of non-
conductive areas. PV isolation has been shown to be effective in the treatment of 
paroxysmal AF  with success rates of 65-80% for multiple surgeries and 40%19 for 
single ablations (see Figure 5B). However, ablation procedures are invasive, can be 
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up to 5 hours long with significantly damage to the atrial tissue and have high 
recurrence rates. 
The effects of different anti-arrhythmic treatments have been investigated using 
computational modelling. For example, Trayanova et al. have reviewed the impact 
of current modelling studies on the understanding of resynchronisation therapies 
and drug treatments. The review is focused on the application of highly detailed 
biophysical models and suggests that these can augment clinical studies and 
elucidate novel treatment methods.21 Furthermore, computation modelling is 
suggested as particularly useful for predicting ablation therapy targets22. Ablation 
therapy requires more information about electrophysiological substrate and wave 
dynamics that currently cannot be accurately measured in the clinic. Therefore, 
modelling can be used to bridge the gap between available measurements (such as 
patient MRI and electroanatomical mapping, as well as ex-vivo, data) and therapy23.  
Figure 6. Flow diagram of the factors contributing to the genesis of AF. It shows the positive 
feedback loop that describes the notion “AF begets AF”.  
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2.3.2. Mechanisms of AF 
High-frequency electrical activity in AF is believed to be sustained by multiple re-
entrant circuits. For re-entry to occur a trigger and suitable substrate are required, 
both of which are facilitated by atrial remodelling. The extent of remodelling is 
increased during AF progression and completes a positive feedback loop (Figure 6) 
which explains both the progressive nature of the disorder and the notion “AF 
begets AF”.24 
Figure 7. Current theories for re-entrant AF drivers. A: the leading circle theory, although 
the core is excitable, it is maintained in a refractory state by impingement of the wave tip. B 
and C: the rotor theory, where the broken wave forms a tip and rotates as a spiral 
waveform around and functionally non-excitable core (the arrows indicate conduction 
velocity). The wave is formed around a core of a minimum radius of rotor propagation. D: 
the multiple wavelet theory that chaotic small waves randomly activate the tissue. Images 
A and B from Zipes & Jalife25 and C and D from Schotten et al.26 
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Figure 8. Mechanisms for AF initiation and sustenance. See Figure 7 for the flowchart of AF 
genesis. A shows the mechanisms for ectopic triggers, in this case focussing on the potential 
role of calcium currents. B shows the determinants for the dynamics of re-entry arising from 
the triggers, particularly its dependence on the wavelength.  Figure from Nattel & Dobrev.27 
When the wavelength is sufficiently short the tissue can provide substrate for the 
wave to re-enter (Figure 7).  Due to the repolarised tissue ahead of the wave this 
cyclic propagation is not self-terminating. Re-entry can occur around an obstacle 
(Figure 7A) such as a pulmonary vein or around damaged non-excitable tissue. 
However this may not always be the case, a further theory predicts a functional 
rotor as the main mechanism for cyclic re-excitation during AF28,29. The theory 
states that the rotor has a tip arising from a wave break and rotates around this 
singular point. This has been shown to occur in multiple simulations and animal 
tissue experiments, but is still contested in patients due to limited clinical 
observation30. It may be the case that because rotors meander, i.e. the tip or core 






source. Recently published data from panoramic electro-anatomical mapping of AF 
patients have provided the first direct  evidence for the existence of rotors in a 
clinical setting.31 
There is much debate concerning the specific dynamics of re-entry, particularly 
whether the atria can sustain multiple separate re-entrant circuits or if the 
stochastic behaviour of AF is caused by the after effects of a single mother rotor.32  
The former, first hypothesised by Moe et al.33, suggests there is no single re-entrant 
source but rather, the wave breaks into multiple wavelets, propagating and 
colliding and breaking into further small waves (Figure 7D).    
2.3.3. AF Triggers 
When the wavelength is sufficiently short and structural or functional obstacles are 
present in the atria, fibrillatory re-entry cannot occur without an initial stimulus or 
trigger. Spontaneous ectopic activity in atrial or PV cells has been observed in-vivo34 
and can produce high frequency waves that propagate throughout the atria. The 
mechanisms for myocytes developing autonomic activation is not fully understood, 
and in-silico modelling and in-vitro cell experiments can only partially reproduce 
these effects. Re-entry can be triggered in patients and large animal models 
through rapid pacing, which mimics rapid spontaneous bursts of action potentials 
associated with ectopic triggers for AF. During high frequency pacing uni-directional 
block can occur, which can initiate re-entry35. EAD and DAD (Figure 8) have been 
suggested as mechanisms for this behaviour.  
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2.3.4. AF Substrate 
Substrate for re-entry refers to various electrophysiological and structural 
properties of the atria that make re-entrant conduction and AF possible. The 
mechanisms for re-entry initiation are commonly due to wave slowing and 
subsequent wave break, with diverse underlying causes ranging from atrial 
geometry and structural obstacles, to ionic heterogeneity and non-uniform 
refractoriness. Re-entry sustenance is not only facilitated by slow conduction but 
also reduced refractoriness, as both factors contribute to a reduced wavelength. 
Such factors are enhanced by AF-induced remodelling.  Remodelling can lead to 
altered densities of ionic channels and gap junctions, reduction of the action 
potential duration (APD), loss of cell-to-cell coupling, as well as fibrosis and 
increased atrial size due to dilatation or hypertrophy36,37,38.  
Moreover, due to the fibrous structure of the tissue and the predominantly end-to-
end coupling of the cells, the propagation of the wave is biased along the fibre. If a 
wave travels transversally across these fibres, part of the wave can travel faster 
causing deformation, which could break the wave and create a rotor. In some 
regions of atrial tissue, sharp changes of fibre orientation occur (e.g. PV trunks,CT 
and pectinate muscle junctions). It has been suggested that high local anisotropy 
can cause autonomic activation to produce ectopic waves. 34 These areas may 
increase the likelihood of wave breakdown or blockage due to the longer 
refractoriness of lateral propagation across fibres.  
A closely related effect occurs due to the intrinsic heterogeneity of the 
myocardium. Different atrial regions have different electrophysiological properties 
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and different APD/ERP. If the wave crosses perpendicularly to a border of two 
regions with different APDs, one could be excitable and the other still refractory, 
which can result in the breaking of the wavefront.37,39    
The geometry of the atria provides another complex contributing factor for AF. The 
irregular atrial wall thickness has been suggested as a substrate for AF 40 due to the 
sink-source relationship. The theory states that due to the curvature or increase of 
thickness of atrial wall the current has to diffuse into a larger volume. Due to the 
current being divided between a much larger number of cells, they each have a 
lesser electrotonic current, which slows the conduction and facilitates wave breaks 
and re-entry.  This effect can also occur as a result of high wavefront curvature.41   
2.3. 5. Ionic Remodelling 
The progressive and treatment-resistant nature of AF suggests a physiological 
positive feedback loop as mentioned in section 2.3.4. Functional and structural 
remodelling have been suggested as mechanisms for this and has a profound effect 
on arrhythmogenesis.  
Ionic remodelling has been shown to promote AF42. By changing the electrical 
properties of the cells it reduces the APD/ERP and wavelength, increasing the risk of 
re-entry. The APD/ERP reductions are promoted by the underlying changes of ion 
channel currents. Specifically, the decreased plateau phase is mostly due to down-
regulation of Ca2+ currents and the acceleration of repolarisation due to up-
regulation of K+ currents. 
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The reason for this response is incompletely understood, but it may be 
compensatory and preventative; one example of this is the case of Ca2+, overload 
where ionic remodelling prevents cell death43. During rapid electrical activations, 
myocytes risk calcium overload, which can become cytotoxic43 and contribute to 
cardiac failure24. To counteract this, the cells remodel the L-type calcium channels 
to reduce the influx of calcium. Although this “last ditch” preventative reaction has 
the negative effect of reducing the ERP, which in turn perpetuates AF.    
Figure 9. Cellular effects of AF-induced ionic remodelling. A shows changes of AP 
morphology due to remodelling during AF39 (four different AF cases are shown). B shows the 
underlying changes in the ionic channel current densities for the case of AF-4. These are 
based on experimental data from literature.42 Image A is reproduced from Colman et al. 39 
The remodelling effects in the repolarisation phase are mediated predominantly by 
changes of IK1 and IKAch, with the latter current activated by the vagal nerve 
stimulation which releases acetylcholine (Figure 9). Increased acetylcholine release 
is known to stabilise AF44. Remodelling of some other currents, such as IKur, and its 









































2.3.6. Structural remodelling 
Structural remodelling changes tissue morphology, and hence affects conduction 
pathways, and may affect re-entrant circuits. Cardiac hypertrophy or dilatation 
enlarges the atria, increasing the potential size of the circuit which promotes re-
entry. This form of remodelling is often a response to hypertension. Structural 
remodelling can also affect the gap junctions, with altered levels of expression and 
localisation on the myocytes, although precise changes during such a re-localisation 
are debatable43.  
Structural remodelling can also be expressed as fibrosis which is a process that 
deposits collagenous matrix in response to mechanical stress on the atria, which in 
turn may be induced by a number of factors. Fibrosis is the formation of excessive 
extra-cellular matrix and collagenous tissue deposited by fibroblasts and can occur 
in all tissues in the body.  
Fibrosis may be initiated by a number of factors such as cell damage, hypertension, 
paracrine stimulation and AF progression46. It is initiated by transforming growth 
factor beta (TGF-β)46 which causes fibroblasts to proliferate and begin depositing 
collagenous matrix.  
Fibroblasts account for up to 60% of the cellular population within cardiac 
tissues47,48, and are reparatory cells, responsible for the deposition of extra cellular 
matrix. However due to the low regenerative ability of cardiac tissues, pathological 
fibrotic scarring can occur due to the high density of fibrous matrix. This can result 
in reduced functionality of the tissue and creates several compounding effects on 
the electrophysiological properties of the tissue.  
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Large areas of naturally occurring dense fibrosis can be referred to as ‘scar’ or 
compact fibrosis (Figure 10); this is functionally similar to fibrotic ‘scar’ induced as a 
result of ablation. To prevent confusion, in this work, scar will refer to fibrosis from 
ablation lesions and dense as disease related compact fibrosis. Dense fibrosis be 
imaged in AF patients using delayed gadolinium enhanced MRI (see Chapter 5). This 
type of fibrosis can block the conduction of waves, initiating re-entry, and may 
become sites of rotor anchorage 49. 
Less severe regional collagen density, where strands of functional tissue are still 
present and conduction can still occur is known as patchy fibrosis (Figure 10). This 
morphology of fibrosis is inhomogeneous. The collagen deposits effectively slow 
conduction. From a macroscopic viewpoint the tissue is proportionally less 
excitable, with current from the fewer cells being diffused over a larger area. At a 
microscopic level, the wave has to travel in a more emphasised zig-zag pattern 
(Figure 11) due to the alignment of collagen deposits and the myofibres50. This 
latter case also suggests that higher anisotropy is associated with patchy fibrosis as 






Figure 10. Types of fibrosis (from left to right); interstitial fibrosis, which is present in 
normal healthy tissue as extracellular matrix. Compact fibrosis (often referred to as scar) 
consists of dense fibrosis devoid of myocardial cells. Diffuse fibrosis describes a uniform low 
level increase in fibrosis throughout the organ. Patch fibrosis, which describes larger, 
elongated collagenous bundles that run in parallel with the myocardial fibres.52 Scale bars 
are 1mm. 
Diffuse fibrosis (Figure 10) describes the least severe type of fibrosis. It consists of 
small deposits of collagen spread evenly throughout an area. Diffuse fibrosis usually 
occurs throughout the whole tissue, and is indicative of a systematic disorder rather 
than a regional one.  Diffuse fibrosis also reduces the conduction velocity but to a 
lesser extent than patchy fibrosis53.  
In addition to the structural effects of fibrosis, the fibroblast cells may also 
contribute to arrhythmogenesis. It has been shown that they have a paracrine 
influence on the myocardium54 and may influence the structural55 and 
electrophysiological properties.47 Although they do not produce an AP they can 
conduct current through gap junctions with myocytes56, and hence act as an 
electrotonic load on myocytes. They also possess active ion channels (Chapter 




Figure 11. Conduction slowing as a result of zig-zag propagation. Lateral conduction across 
the tissue sample is reduced due to the tortuousness of the conduction pathway.52 
The combination of gap junctional coupling and the resting potential difference 
between myocytes and fibroblasts creates a current between the two cell types. 
The coupled fibroblasts (one or more) produce a damping effect to the myocyte, 
reducing the AP upstroke and affecting the repolarisation and ERP. This could also 
reduce the conduction velocity due to the loss of current to the fibroblasts by 
reducing the current transferred to the next myocyte.  
2.4. Mathematical modelling 
Clinical investigation of AF is problematic, since direct measurements of atrial 
electrophysiology in patients is mostly limited to minimally invasive methods that 
have poor resolution or are confined to small areas of endocardium. Many studies60 
are focused toward the inverse problem, which uses body surface 
electrophysiological mapping to non-invasively to calculate the wave dynamics in 
the atria. However neither approach gives insights to the role of underlying 
structures or ionic properties of the tissue, and therefore currently have limited 




Animal testing has been useful in developing knowledge of AF as it allows for more 
invasive measurement of the disorder in combination with dissection of the tissue 
structure. The histology identified from this method has informed detailed cell 
models and provided physiological information that cannot be obtained from 
patients. However animal experiments also have limitations, predominantly the 
inherent differences between animals and human anatomy and physiology.61 
Therefore unequivocal conclusions about human electrophysiology may not be 
made. Moreover, animal studies can rarely achieve true integration of in-vitro cell 
and tissue data and in-vivo organ level experimental data. 
Biophysically detailed modelling presents an opportunity to observe cell-to-organ 
electrophysiological dynamics with clinically relevant properties, ethically and with 
reduced expense. Due to the quantitative nature of computational modelling, it is 
possible to dissect individual parameters of the simulation that cause the largest 
changes to the arrhythmogenic wave dynamics in order to identify more significant 
factors for the development and sustenance of AF. 
2.4.1. Cell electrophysiology modelling 
The foundation of all electrophysiological modelling was laid by Hodgkin and Huxley 
earning them the Nobel Prize in Physiology or Medicine in 1963. Their model 
simulates the action potential in a giant squid axon. This was achieved by 
approximating each excitable cell as an electric circuit, a capacitance represents the 
cell membrane, time and voltage dependant conductances represent specific ionic 
currents and electrochemical gradients are represented by batteries.  
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In their model all specific ionic channel current kinetics are simulated with 
activation and inactivation variables, which represent the relative proportion of 
channels within a cell in either active or inactive states. From this relationship it is 
possible to calculate the ionic current of a particular ion across the cell membrane 
(equation 2).  
𝐼𝑖𝑜𝑛 = 𝑚
𝑎ℎ𝑏𝑔𝑚𝑎𝑥(𝑉𝑚 − 𝐸𝑖𝑜𝑛)            ( 2) 
Where m and h are activation and inactivation gating variables, gmax is the 
maximum conductance, Vm is the membrane voltage, Eion is the Nernst equilibrium 
potential. The Nernst equilibrium potential is the point of equilibrium between the 
gradient of charge and the gradient of concentration so that transmembrane ionic 







               ( 3 ) 
Where R is the universal gas constant, T is the absolute temperature (Kelvin), F is 
the Faraday constant, z is the valence number and [ion]e/i are extracellular and 
intracellular ionic concentrations. Using the Nernst equilibrium potential it is 
possible to calculate the driving force. This describes the difference between the 
membrane potential and the equilibrium potential, which then drives the ionic flux, 
Iion , through conducting channels, collectively characterised by the conductance 
gmax. In cases where currents are not ion-specific and are dependent on multiple 
ions, the ionic current (2) is considered as the linear sum of the currents carried by 
individual ions, with each current characterised by a relevant Nernst potential (3).  
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Hodgkin and Huxley used voltage clamping, an experimental method for 
characterising ionic channel currents in vitro, by incrementally increasing a constant 
voltage applied across the cell membrane. From these experiments they were able 
to formulate the time and voltage dependence of activation and inactivation gates.  
Considering pi as the probability that gates of type i are open (for example m or h in 
equation with a range of 0-1 and pi(t) is the fraction of gates open at time t then 1-
pi(t) is the fraction that are closed.  To transition between open and closed states 
two rate coefficients are required; αi and βi, both of which are voltage dependant. 
Percentage closed  αi(t)  Percentage open 
1-pi(t)  βi(t)  pi(t) 
   
So therefore the change in probability of the state of the gates is 
𝑑𝑝𝑖
𝑑𝑡
= 𝛼𝑖(𝑉𝑚)(1 − 𝑝𝑖) − 𝛽𝑖(𝑉𝑚)𝑝𝑖                                          ( 4 ) 
If the voltage is fixed or clamped at value Vm, the gates will tend towards a steady 
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The total membrane current, Im, is a sum of the capacitive and ionic currents and 




= − ∑ 𝐼𝑖𝑜𝑛 = −𝐼𝑡𝑜𝑡                      ( 9) 
Where; Cm is the membrane capacitance, Itot is the total ionic current carried by 
various ions. This ordinary differential equation (ODE) can be solved with the simple 
Euler method with a time step of 0.005ms, which has been shown to work well for 
most existing ODE-based cardiac cell models48, including the one used in this study 
(section 2.5). 
2.4.2. Tissue modelling 
While it is possible to model discrete tissue, where cells are individually modelled 
and coupled, it is computationally expensive and not viable for large-scale 3D 
simulations. Continuum models are used to approximate the simulated tissue 
domain in the 3D space. Two main types of continuum model are used; the 
monodomain model (equation 10) which assumes the intra and extracellular 
conductivities are the same and the bidomain model which does not. Although the 
bidomain is arguably a better approximation of reality, in larger-scale simulations it 
has been shown to yield little difference in results62 although useful if simulating 
external stimuli63. The monodomain equation can be written as: 
𝜕𝑉𝑚
𝜕𝑡
= 𝛻 ∙ (𝑫𝛻𝑉𝑚) −
𝐼𝑡𝑜𝑡
𝐶𝑚
            ( 10 ) 
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where ∇ is the 3D gradient operator and D is the diffusion coefficient, which can be 
a tensor if the tissue is anisotropic. 
2.4.3. Numerical solvers 
The continuous equations, such as equation 10, require discretisation in order to be 
solved using an iterative numerical procedure in simulations. This is because 
analytical solutions are not generally possible for nonlinear partial differential 
equations (PDEs). There are various numerical methods such as finite element and 
finite volume, which provide approximate solutions for these PDEs and have been 
applied specifically to electrophysiological modelling. In this section we will only 
consider the method used in this thesis.  
The finite difference method (see equation 12) is the most common method of 
calculating spatially discretised voltages in 3D tissue described by the monodomain 
equation. The method divides the simulation space into a regular grid with a 
spacing Δx. Although Δx can generally vary throughout the geometry, in this work it 
will be constant.  
The numerical solver used is the forward Euler method. It provides a simple 
numerical algorithm for differential equation integration by assuming that the 
change in y is constant for a small change in t. A generalised method is shown 
(equation 12) for the ordinary differential equation (equation 11). The space step 
used was 0.33mm as this was compatible with the established geometric datasets 
used in this work (Chapter 4 ). 
𝜕𝑦
𝜕𝑡
= 𝑓(𝑦, 𝑡)                                                                   (11) 
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𝑦𝑡+𝑑𝑡 = 𝑦𝑡 + 𝑑𝑡 × 𝑓(𝑦𝑡 , 𝑡)                                         (12) 
When applied to the monodomain equation (expression shown here describes a 1D 
case) voltage can be calculated (at a time t=t+Δt): 
𝑉𝑡+∆𝑡 = 𝑉𝑡 +
𝐷∆𝑡
∆𝑥2
(𝑉𝑥+∆𝑥,𝑡 + 𝑉𝑥−∆𝑥,𝑡 − 2𝑉𝑥,𝑡) −
∆𝑡𝐼𝑖𝑜𝑛
𝐶𝑚
                 (13) 
Using this simple solver is less computationally expensive that other methods but 
can be prone to instability. For a stable simulation the criterion (equation 14) must 
be maintained. This is shown a constant diffusion coefficient in N-dimensional 
space, which can be also applied as a sensible practical estimate for non-linear 




                                                                   (14) 
2.5. Cardiac electrophysiology modelling 
Most electrophysiological cell models are based on the Hodgkin-Huxley 
formulation, and have been modified to represent cardiac electrophysiology64,65. 
These models simulate a diverse range of pathophysiologies relevant to AF, e.g. 
chronic heart failure remodelling, or drug therapies. This section outlines the 
various cardiac models used in this work and details their properties.  
2.5.1. Courtemanche-Ramirez-Nattel atrial myocyte model  
Although other cardiac myocyte models exist (Fenton-Karma,66 Grandi et al.67), the 
Courtemanche-Ramirez-Nattel (CRN) was used in this work, as it provides high 
biophysical detail and has been extensively studied.  The CRN model64 developed in 
1998 is one of the earliest atrial myocyte models. It was developed to provide a 
useful model of the atrial AP based upon their specific formulations of K+, Na+ and 
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Ca2+ currents. The schematic in Figure 12 shows the relevant ionic channels and the 
sarcolemic calcium channels. AP morphologies simulated using the CRN model are 
illustrated in Figure 10. Properties of this model have been extensively studied.48 
Figure 12. Schematic of Courtemanche- Rameirez-Nattel model. The cell membrane, in light 
blue is representative of the phospho-lipid bilayer that maintains the capacitance of the cell. 
The yellow shapes along this membrane indicate the various currents present in this model. 
In the centre of the figure is a further membrane that isolates the sarcoplasmic reticulum 
(JSR and NSR) from the cytoplasm. Figure from CellML model repository. 
2.5.2. Modelling arrhythmogenic properties 
During AF multiple physiological properties change due to remodelling or have 
inherent parametric variation. There have been many previous studies38,42,68 that 
used existing models such as the CRN model and modified parameters (e.g., ion 
channel conductances) to simulate such pathophysiological conditions. Due to the 
wide range of the conditions associated with AF, there is an equal numerous 
models investigating these conditions.  In this study we utilised such modifications 
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of the CRN model for ionic remodelling, regional heterogeneity and myocyte-
fibroblast coupling.   
Within the atria there are natural electrophysiological variations between different 
tissues. These variations can culminate in gradients of AP variation that have been 
linked to arrhythmogenesis. Colman et al.69 created a comprehensive model of all 
the regional APs achieved by altering conductances of different channels to 
matching the model to experimental data. Figure 13 shows the resultant AP 
variations. This study applies this family of region-specific atrial cell models both in 
1D and 3D.  
Ionic remodelling (as discussed in section 2.3.5) was also investigated. The 
respective model, also developed by Colman et al.,42 modifies  ionic current 
densities based on experimental data (similarly to how this was done to introduce 
the regional heterogeneity), in order to simulate the effects of ionic remodelling in 
AF. The effects on ionic currents and AP can be seen in Figure 9.  
A further modification to the standard CRN model was the inclusion of myocyte-
fibroblast (M-F) coupling. A novel single fibroblast cell model was developed 
(Chapter 3) with ionic currents based on the CRN formulation. Another, existing 
ventricular fibroblast model was utilised for comparison. The details of these 




Figure 13. Regional heterogeneity of the Colman et al. atrial myocyte model. A, shows the 
simulated APs of the regions in the right atrium; PM, RAA, CT, BB and AS. B shows the 
simulated APs of the regions located within the LA, LAA, AVR, PV. C is a bar chart of the 
APDs of the regions throughout both atria. Graphs sourced from Colman et al.38 
2.6. Magnetic resonance imaging 
Various aspects of this study are reliant on structural data obtained from patients 
and healthy volunteers using magnetic resonance imaging (MRI). The method uses 
magnetic field to measure proton spin changes in water molecules. Different tissues 
of the body have different quantities of water in their structure and provide 
resonance contrast. A novel black-blood phase-sensitive inversion recovery 
sequence (PSIR) was used to maximise the contrast between the atrial wall, blood 
and lung70. This allowed us to investigate variance in the atrial wall (Chapter 6) and 

































images were used to investigate fibrosis distributions in patients (Chapter 5). These 
images had a higher resolution of 2.5x2.5x4mm. This method uses an intravenous 
contrast agent, Gd, that perfuses into the myocardium71. Regions of high fibrosis 
have higher residual gadolinium content and higher image intensity.  
 
Figure 14. Cardiac MRI examples. A shows a LGE MRI of a patient with permanent AF. B 
shows a PSIR MRI image of a persistent AF patient. White scale bars are 10mm. 
2.7. Conclusion 
Due to the progressive treatment resistant nature of AF it is clear that better 
understanding is required to improve treatments. Furthermore, detailed 
measurement of in-vivo electrophysiology and atrial structure is currently 
unavailable. Computational modelling provides the perfect link for developing 
understanding   of this condition.  
A                            B 
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3. Myocyte-fibroblast coupling model 
3.1. Introduction 
Fibrosis is a multifactorial degenerative condition that is commonly associated with 
AF progression. Different pathophysiological mechanisms have been suggested as 
links between atrial fibrosis and AF. One of the primary links involves the 
intracellular deposition of collagenous matrix by cardiac fibroblasts. these cells are 
present in most tissues in the body and makes up 60-70% of the cardiac cell 
population72. Although fibroblasts are more abundant than the cardiac myocyte, 
they are much smaller than myocytes, at around 10-15µm compared to 100µm 
length of the myocyte. Thus, fibroblasts provide a smaller contribution to the atrial 
tissue volume. Fibrosis can affect atrial tissue structure through excessive collagen 
depositions and by electrophysiological function through electrotonic coupling 
between fibroblasts and myocytes. 
3.1.1. Cardiac fibroblasts 
In a healthy heart, fibroblasts are responsible for maintaining the structure of the 
tissue against stress and damage. They act dynamically, modifying and remodelling 
the atrial structure driven by changes in the mechanical requirements of the organ. 
This action is modulated by paracrine signals which can increase the localised 
populations, proliferation and/or activity of fibroblasts.73 The causes for fibrosis 
initiation are unclear, but may be due to hypertensive stress response (i.e. 
mechanical stretch), localised ischemia or neuro-hormonal activity.  
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Under these  pathological conditions, which may be caused by heart failure or 
localised tissue damage, dormant fibroblasts can differentiate into the phenotype 
known as myofibroblasts74. In this activated form fibroblasts proliferate, migrate, 
activate an inflammatory response and produce more collagen, creating a higher 
level of matrix deposition75. The phenotypical differences between the 
myofibroblasts and the fibroblast are underlain by various gene expressions of the 
cell in its active form76. Atrial tissue is more susceptible to fibrosis than ventricular 
tissue,77 78 which may be due to TGF-β being higher in atrial than ventricle 
fibroblasts 79 or that atrial fibroblasts have a higher propensity to differentiate into 
the more active myofibroblast 78. A note must be made that for the rest of this 
report the term myofibroblast will be generalised and referred to as fibroblasts. 
3.1.2. Fibroblast electrophysiology 
Unlike myocytes, fibroblasts are not electrically excitable, however they can 
maintain a resting membrane potential (RMP), and hence affect and be affected by 
the tissue electrophysiology. Myocyte-fibroblast electrotonic coupling has been 
observed in-vivo and in vitro, current exchange between fibroblasts and myocytes 
was first confirmed in frogs80 and later in rats81 . The M-F coupling mechanism uses 
gap junctions, in the same manner as inter-myocyte coupling. These gap junctions 
are comprised of proteins connexin-43 and 45 (Cx43, Cx45), which have been 
observed in co-cultured neonatal rat fibroblasts and myocytes.81,82 This was 
followed with  in-vivo observation of Cx45 expressed by fibroblasts in rabbit SAN.83 
Tunnelling nanotubes or membrane nanotubes have been investigated as another 
gateway permitting M-F interaction. These pathways can directly link the 
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cytoplasms of myocytes and fibroblasts84 allowing for ionic transfer, in particular 
the active transport of calcium ions.84  
 
Table 2. Electrophysiological properties of cardiac fibroblasts. The table identifies ionic 
channel currents and RMP of fibroblasts as researched in literature. *(gadolinium 
sensitive),†(mechanosensitive), ‡  big conductance Ca2+, **(volume sensitive) -activated K+ 
current has been reported in some studies of cultured cells. 
The electrophysiological function of fibroblasts is determined by the presence of a 









Wu et al.85 -42.8mV  (LA) 














-58 ±3.9mV Ins, IKv Adult  
rat ventricle 
 
Chilton et al.59 - IK1,IKv Rat ventricle isolated 
Kiseleva et al.87 -22mV - Rat atria isolated 
Rook et al. 81 -20 ÷ -30mV - Neonatal rat cultured 
Kamkin et al.88 -37±3 mV Ins
 * Rat atria  
Wang et al.89 - Ins
†, IBkCa
‡ Rat ventricle cultured 
Miragoli et al.90 -14 ÷ -25mV IK1 Neonatal rat 
ventricle 
cultured 




Kohl et al.80 - ICl, IKv, IK1, INa Frog SAN  
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cultured and freshly isolated fibroblasts express voltage dependant potassium 
channels (IKv)
59,74,85,90,80. A wide variety of currents have now been discovered in the 
cardiac fibroblast, predominantly potassium (IKur, IKir, Ito), but also non-specific ionic 
currents (Ins) which can be mechanically and non-mechanically activated and 
chlorine (ICl). The sources of data for these various currents are diverse, and are 
summarised in Table 2.  
Some of this data should be treated cautiously, due to the differences in cellular 
physiology between cultured and intact cells74,91. A further consideration is the 
variation between atrial and ventricular electrophysiology, which is also observed in 
fibroblasts85,91 as well as myocytes38. The differences in fibroblast electrophysiology 
have been suggested as potential drivers for the variation in fibroblast population 
between the atria and the ventricles, which is higher in the atria92. Due to these 
observed differences, ventricular models may not be suitable for investigating atrial 
electrophysiology. The most comprehensive study of atrial fibroblast 
electrophysiology has been published recently by Wu et al.,85 who explored the 
variations between atrial and ventricular fibroblasts in freshly isolated cells.  
The presence of ionic channel currents in fibroblasts leads to the generation of RMP 
in the fibroblast. Direct measurement of the RMP in fibroblasts shows more 
positive values (from -58 mV in the ventricles and up to -15 mV in the atria, shown 
in Table 2) than RMP in myocytes (about -80mV). Other electrophysiological effects 
of M-F coupling on the myocyte have been found. Miragoli et al. found in co-
cultured myocytes and fibroblasts that, as the relative concentration of fibroblasts 
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increased, conduction velocity and maximum upstroke were reduced. This may be 
due to the higher RMP of the fibroblast depolarising the myocytes.90 
3.1.3. Modelling of fibroblast electrophysiology 
There has been previous research using computational modelling to investigate the 
effects of M-F coupling and the subsequent electrophysiological effects of fibrosis. 
In-silico research is beneficial due to the difficulty of in-vivo measurement of 
cellular electrophysiology. These have ranged from simple passive models93, with 
only a resistive gap junction connection and no fibroblast ionic channels, to 
complex models with time and voltage dependant ionic currents58,94,95. 
The state of the art fibroblast model is the MacCannell et al.58 model and its 
derivatives. These are based of the electrophysiological findings on Shibukawa et 
al.86 which identify IK1 and IKv in ventricular fibroblasts. IKv is an amalgamated time 
and voltage dependant potassium current. The subsequent variations of this model 
vary parameters in order to identify different behaviours of M-F coupling, such as 
RMP influences92 of different coupling strengths and propagation95. Sachse et al.,94 
built a competitive model based on the same results and Chilton et al.59 
investigated the effects of M-F coupling on conduction. Zlochiver et al.96 utilised a 
cell culture and a fluoroscopic dye to initiate re-entry to validate their model. A 
passive (with no fibroblast ionic currents; simply a membrane resistance and resting 
potential) computational model was used to quantify the conduction. They found 
that the M-F coupling had complex effects on conduction velocity, re-entry stability 
and wave complexity. 
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A further passive model was developed by Maleckar et al.93  in for comparison with 
the MacCannell et al. model. The findings of the latter last study demonstrated that 
M-F coupling to an active fibroblast model created complex behaviour and changes 
to the AP which must be considered when investigating AF.  
Table 3. Summary of previous computational studies of cardiac fibroblasts. Showing the 
RMP, the modelled ionic currents of the fibroblast, the gap junction conductance (Ggap), 
the number of fibroblasts and the animal cell type. 
Due to the difficulty of obtaining human electrophysiological data, the sources of 
data for these models are varied. Most come from animal94,95 and/or ventricular 
studies58, neither of which are not ideal for the investigation for atrial fibrosis and 







Animal Cell type 
MacCannell et al. 
58 
-47.8 IKv, IK1, 
INaK, IbNa 
1-3 1-4 Human Ventricle 






1-3 Human Atria 
Jacquemet et al.92 - - 0.2-
138 
2-8 Canine Ventricle 
Jacquemet et al.95 - - 138 
 
30 Canine Ventricle 
Sachse et al.94 -58 Ikir*, IKv*, 
Ib 
- 1-10 Rat Ventricle 
Zlochiver et al.96 -15.9 - - 1 Neonat
al rat 
Ventricle 
Kohl et al.80 -20mV - 0.01-
0.03 
1 Rat SAN 
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electrophysiology data in order to develop a more complex and representative 
electrophysiological model of the atrial fibroblast.  
The aim of this work is to build a specific atrial fibroblast model based on the most 
comprehensive electrophysiological data. The remainder of this chapter described 
the creation of this model and the results obtained using it. 
3.2. Methods 
The framework for modelling the atrial fibroblast electrophysiology is based on a 
ventricular fibroblast model by MacCannell et al.58 which is also used as a 
benchmark in this chapter. However, several novel ionic channel currents were 
added to this framework, which were based on the CRN formulation of the currents 
for human atrial myocytes and experimental data from atrial fibroblasts.  
Data for the atrial fibroblast model was obtained from a study on fibroblast ionic 
currents in freshly isolated human atrial fibroblasts by Wu et al.85. By analysing the 
figures using the data extraction software Scanit(R), the relevant current-voltage (I-
V) relationship data was extracted and then superimposed onto the respective 
simulated curves in Matlab(R). An optimal fit between the modelled ionic currents 
and experimental data was achieved by varying the current conductances. The 
results of this can be observed in Figure 15.  
3.2.1. Modelling ionic currents 
The model is based on the CRN formulation of the ionic channel currents in a 
human atrial myocyte and incorporates experimental data for the ionic currents 
recorded by Wu et al. from atrial fibroblast.85  Three currents are measured by Wu 
et al. and are described as end-pulse current, 4-aminopyridine (4-AP) sensitive 
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current and S9941 sensitive current. In the same study the RMP of the isolated 
atrial fibroblasts was also measured and used to validate the model.    
The 4-AP sensitive current was modelled as Ito,f, for which 4-AP is a selective 
blocker. Fitting this current to experimental data by Wu et al. involved a 90% 
reduction in the current conductance compared to the CRN model (Figure 15A), but 
no changes to the current kinetics was introduced. 
The S9941 sensitive current was modelled as IKur,f, as S9941 is a blocker of ionic 
channels containing the subunit Kv1.5, which forms the channel conducting this 
current. Fitting this current to experimental data by Wu et al. involved a 40% 
reduction in the current conductance compared to the CRN model (Figure 15B). 
The end pulse current was measured by Wu et al. as the total voltage sensitive 
current. We considered the remainder of this current after subtracting both Ito,f and 
IKur,f as a sum of a further two currents: a linear non-specific ionic channel current, 
Ins,f, and the inward-rectifier potassium channel current, IK1,f (shown in Figure 15C). 
Both IKur,f and Ins,f are major contributors to the fibroblast RMP. The separation of 
these two currents ensured that IK1,f reverses at the equilibrium Nernst potential for 
potassium, which is observed in electrophysiological recordings of this current in 
multiple cell types. The voltage and time dependences for these four currents are 
described by the following equations, based on the CRN formulation (note that 




                                                        (15) 
𝐼𝑛𝑠,𝑓 = 0.018 𝑉𝑓                                                                  (16) 
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𝐼𝑡𝑜,𝑓 = 𝑔𝑡𝑜,𝑓 ∗ 𝑜𝑎,𝑓
3  ∗ 𝑜𝑖,𝑓 ∗ (𝑉𝑓 − 𝐸𝐾,𝑓);                                          (17) 
𝐼𝐾𝑢𝑟,𝑓 = 𝑔𝐾𝑢𝑟,𝑓 ∗ 𝑢𝑎,𝑓
3  ∗ 𝑢𝑖,𝑓 ∗ (𝑉𝑓 − 𝐸𝐾,𝑓);                                       (18) 
Here, Vf is the membrane voltage of fibroblasts, where oa,f, ua,f and oi,f, ui,f  are 
activation and inactivation gates respectively and gKur and gto are conductances of 
the respective channels. 
Other currents in the developed model are based on the MacCannell et al. 
formulation, specifically those not measured by Wu et al.85 but assumed present in 
the fibroblast were based on experimental studies with other cardiac cells types. 
These are the sodium potassium exchanger (INaK) and the background sodium 
current (IbNa). The entire fibroblast model is included in the appendix.  
In the MacCannell et al. model and its derivatives, IK1 and the time and voltage 
dependant current IKv is simulated. This current was shown to be sensitive to 4-AP 
and S9941 in their experimental work86 but modelled as a single current. It is based 
on the human atrial current IKur and is given by the expression bellow: 
𝐼𝐾𝑣 = 𝑔𝐾𝑣 ∗ 𝑟𝐾𝑣  ∗ 𝑠𝐾𝑣 ∗ (𝑉𝑓 − 𝐸𝐾,𝑓);                                           (19) 
where rKv and sKv are the activation and inactivation parameters respectively.  
3.2.2. M-F coupling model  
In order to simulate the coupling of fibroblasts to a myocyte we used a similar 
model to that developed by MacCannell et al. The myocyte model (detailed in 
Chapter 2) was the CRN atrial myocyte model. The fibroblast with a total membrane 
current Itot,f was coupled via the M-F gap junctional conductance (Ggap) to the 
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myocyte with the total membrane current Itot. The equations for the M-F coupling 
model are as follows:  
𝐼𝑡𝑜𝑡,𝑓 = ∑ 𝐼𝑖𝑜𝑛,𝑓 =  𝐼𝑡𝑜,𝑓 + 𝐼𝐾1,𝑓 + 𝐼𝐾𝑢𝑟,𝑓 + 𝐼𝑛𝑠,𝑓 + 𝐼𝑏𝑁𝑎,𝑓 + 𝐼𝑁𝑎𝐾,𝑓            (20)                         


























                                     (22) 
Here subscripts m and f relate to a single myocyte and fibroblast and n to the 
number of fibroblasts coupled to one myocyte. Ggap was set as 0.5nS
92 and n was 
varied between 0-6. Unless specified otherwise, a myocyte was coupled to 2 
fibroblasts. 
We also investigated how the M-F coupling model interacted with other 
physiological conditions associated with AF. These were ionic remodelling and 
regional heterogeneity (see Chapter 2)38,42. These parameters (specifically, ionic 
channel conductances changes due to the heterogeneity and remodelling) were 
additionally integrated into the CRN myocyte model.   
3.2.3. Restitution measurement  
All simulations and analyses of the dynamic effects of the single cell models were 
performed in Matlab(R) due to the advantage of easy visualisation. APD90, ERP and 
excitation threshold, as well as their restitutions, were measured to characterise 
the electrophysiological properties of the models. These were all measured after a 
period of 40 beats in order to stabilise all variables in the model and reduce 
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alternans (periodic fluctuations in APD), which can be present in the CRN model at 
high frequencies.  APD90
 was calculated by finding the period of time between the 
maximum upstroke and the AP repolarisation to 90% of the difference between the 
peak amplitude (APA) and the minimum membrane. The advantage of APD90 (as 
opposed to APD60) is that it encompasses phase 4 of the AP, in which M-F coupling 
has a greater effect.  Excitation threshold was measured by incrementally varying 
the stimulus current in single cell until an AP was formed. This procedure was pre-
paced at a range of frequencies allowing for a restitution curve to be plotted. 
The tissue ERP was calculated in a quasi-1D tissue by applying a stimulating current 
at one end to initiate AP propagation to the other end. This was modelled as a long 
3D slab of 50 x 7 x 7 cells with a space step of 0.3mm and a diffusion coefficient of 
0.3mm2ms-1. The stimulus of -2500 mA was applied in the first 10 layers of cells. 
This resulted in a 1D plane wave propagating along the slab. Zero-flux boundary 
conditions were implemented at all sides of the slab. Stimuli were applied at a given 
BCL, followed by a last stimulus applied at a variable S2 interval. The latter was 
increased until an AP was observed at the non-stimulated end of the cable. The 
minimum S2 interval for which AP was still able to propagate through the cable was 
taken as ERP. This simulation also allowed the calculation of the conduction velocity 
by calculate transmission times across the tissue. Both ERP and CV were measured 




Figure 15. Ionic channel currents of the atrial fibroblast model.  A-C: The simulated current 
voltage (I-V) curves for the major ionic currents (solid lines) are shown along with the 
respective experimental data (dots). A. The ultra-rapid current, IKur. B. The transient outward 
current, Ito. C. The experimentally measured end-pulse current (black dots), with the 
simulated inward-rectifier and non-specific currents, IK1 and Ins, (grey lines) and the 
combined current IK1 + Ins (black line). D: IKv simulated by the ventricular fibroblast model by 
MacCannell et al.; it represent the sum of IKur and Ito. Note that the index 'f' used in 
equations (1)-(4) above is omitted here for simplicity.  
3.3. Results 
In this section 3 main conditions are modelled and investigated. The CRN myocyte 
without M-F coupling (i) the atrial myocyte coupled to the novel atrial fibroblast 
model (ii) and the CRN atrial myocyte coupled to a ventricular fibroblast model (iii) 
as developed by MacCannell et al. 
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3.3.1 Single atrial fibroblast model 
The fitting of ionic channel currents in the atrial fibroblast models to the respective 
patch clamp data can be seen in Figure 15A-C. I-V curves for both IKur and Ito in the 
model are in good agreement with the experimental data.  
Figure 15C illustrates fitting of the combination of Ins and IK1 in the model to the 
experimentally measured remainder end-pulse current, again with good agreement 
across the physiological voltage range. Figure 16 compares the current densities in 
the developed atrial fibroblast model, the CRN atrial myocyte model used to derive 
these currents, and the MacCannell et al. model for ventricular fibroblast. 
After fitting the ionic currents to experimental data, the RMP in the resulting model 
for a single atrial fibroblast was -42.5mV, which was in close agreement with the 
respective experimental value of -42.8mV ±1.3 mV recorded from atrial 
fibroblasts85. This value is more positive than the RMP of -48 mV in MacCannell et 
al. ventricular fibroblast model. Note that both -42.5mV in the developed atrial 
fibroblast model and -48mV in the ventricular fibroblast model are within the 
experimental data range (Table 2), but -42.5mV closer corresponds to RMP in 





Figure 16 Ionic current density in the single cell models. Different currents are compared 
between the uncoupled myocyte (blue), the atrial M-F model (green) and the MacCannell et 
al. (red) M-F model. All current densities are measured in pA/pF. 
3.3.2 Myocyte-fibroblast coupling model 
Coupling to fibroblasts significantly affected electrophysiological properties of the 
myocyte. Figure 17A and B, illustrates APs in the control CRN model (i) ,coupled to 
the developed atrial fibroblast model (ii), and the CRN model for a myocyte coupled 
to the MacCannell et al. ventricular fibroblast model(iii). In these simulations, a 
myocyte was coupled to 2 fibroblasts. The M-F model (ii) produced prolonged 
repolarisation compared to the uncoupled control model (i), whereas the M-F 
ventricular model (iii) produces a more rapid repolarisation than in control. Hence, 
coupling to atrial (ii) and ventricular (iii) fibroblasts produces opposite effects on AP 
in the CRN atrial myocyte model (i). Figure 17C and D shows the respective 
membrane potential in atrial and ventricular fibroblasts for the M-F coupling 














































































Figure 17. Effects of M-F coupling on AP in the atrial myocyte described by the CNR model. 
A and B shows the AP in atrial myocyte in various conditions; uncoupled CRN model (Blue) , 
CRN coupled with 2 human atrial fibroblasts (green) and CRN coupled with 2 ventricular 
fibroblasts (red).C and D show the fibroblast membrane potential for the coupled models 
and E and F show the M-F gap junction current (IGap). The left hand column (A, C and E) 
shows these conditions at a BCL of 250ms and the right (B, D and F) for a BCL of 500ms.  
 
Figure 18 compares AP characteristics, such as the peak voltage and RMP, in cases 
(i)-(iii). The M-F coupling models (ii) and (iii) had lower peak voltage than the 
control CRN model (i) at a BCL of 300ms (Figure 18A). However at a BCL of 500 and 
1000ms the difference from control were less than 2mV. 
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The RMP (Figure 18B) was increased (became more positive) compared to control 
in both M-F coupling models (ii) and (iii). At a BCL of 500 ms, in the model (ii) with 
atrial fibroblast the RMP was -76.5mV (Figure 18B) and in the model (iii) with 
ventricular fibroblast the RMP was -77.5mV, compared to -79.8mV in the CRN 
model (i). RMP is particularly important during a period of fast pacing (Figure 18B) 
as it can influence the initiation of the next AP. The lowest RMP with atrial 
fibroblasts) is seen across all BCLs. 
Figure 18. AP Amplitude, APA, and RMP of the M-F coupling models.  All plots use the colour 
code: blue= uncoupled CRN myocyte model, green= M-F coupling model with atrial 
fibroblasts and red= M-F coupling model with ventricular fibroblasts. A: APA at BCLs of 300, 
500 and 1000ms, B: RMP at 300, 500 and 1000ms.   
The membrane potential in fibroblasts (Figure 17C and D) for the M-F coupling 
model was purely electrotonic due to the coupling with the myocyte and had 
substantially lower amplitude than that of the myocyte. The atrial fibroblast had a 
slower repolarisation and slightly lower amplitude than that of the coupled 
ventricular fibroblast. More importantly, it also had a higher resting potential 
(Figure 18B).  




































The dynamic effects of coupling a CRN myocyte with the developed atrial fibroblast 
model significantly changed the refractoriness of the myocyte. There was little 
difference in APD between the M-F coupling model with atrial fibroblasts (ii) and 
the control (i) except for at a high pacing rate, e.g. at a BCL of 200ms (Figure 19). In 
comparison, the M-F coupling model with ventricular fibroblasts (iii) reduced the 
APD throughout the range of BCLs, with a maximum reduction of 21ms. Effects of 
M-F coupling on APD became more pronounced in both models (ii) and (iii) as the 
number of fibroblasts coupled to each myocyte was increased from 2 to 4 and 6 
(Figure 20). 
Figure 19. The APD and ERP differences between the M-F coupling models.  A: APD 
differences between M-F coupling models with the uncoupled CRN myocyte model (blue). 
The M-F coupling with atrial fibroblasts is shown in green and the M-F coupling with 
ventricular fibroblasts in red. B: ERP differences between the M-F coupling models and the 
uncoupled model are more pronounced. 
Effects of M-F coupling on ERP were more pronounced than those on APD in both 
M-F coupling models (ii) and (iii). ERP in the M-F coupling model with atrial 
fibroblasts (ii) was larger than that in control (i) by about 5-10ms at BCLs above 
300ms, but dropped off rapidly at BCL was decreased below 275ms (Figure 19B). 






































A                                          B   
   
71 
 
ERP in the M-F coupling model with ventricular fibroblasts (ii) was substantially 
larger than that in control (i) by about 50-100ms across the range of BCLs.  
Figure 20. Effects on APD of the increased levels of M-F coupling. As the number of couple 
fibroblasts in increased up to 6, the M-F coupling model with atrial fibroblasts (A) shows an 
increase in APD, whereas the M-F coupling model with ventricular fibroblasts (b) shows a 
substantial decrease in APD. The colour code is as follows: blue= uncoupled CRN model, 
green= 2 fibroblasts, red=4 fibroblasts and cyan=6 fibroblasts.   
The excitation threshold for the stimulus current was also investigated (Figure 21) 
for the models. In the M-F coupling model (ii) with atrial fibroblasts, the threshold 
was -15.30 pA/pF at the BCL of 400 ms. It was significantly lower when compared to 
both the uncoupled myocyte model (i) (-18.30 mA/mS) and the M-F coupling model 
(iii) with ventricular fibroblasts (-16.70 mA/mS). Changes of the excitation threshold 
in models (ii) and (iii) compared to control CRN (i) correlated with the respective 
changes in the RMP: higher (more positive, but lower absolute value) RMP 
corresponded to the lower excitation threshold (compare Figure 17B and Figure 
20). As the M-F coupling strength was increased (by increasing the number of 
fibroblasts coupled to a myocyte) the excitation threshold was reduced, as seen in 
Figure 21. This can also be explained by the higher RMP in the atrial fibroblast, 





































































resulting in a stronger current flowing from the fibroblast into the myocyte during 
phase 4 of the AP.  
Figure 21. The excitation threshold for the M-F coupling models.  A: the excitation threshold 
for the two M-F coupling models and the uncoupled CRN myocyte model (same colour code 
as Figure 19). B: the M-F coupling model with an increasing number of atrial fibroblasts 
(blue=uncoupled CRN model, green=2 fibroblasts, red=4 fibroblasts). 
3.3.3 Additional electrophysiological effects 
The effects of the ionic remodelling, M-F coupling and M-F coupling combined with 
ionic remodelling, were investigated for comparison between the conditions (Figure 
22A). APD in the CRN model is reduced by 40%, due solely to the ionic remodelling, 
with an additional 1.4% increase when combined with the proposed fibroblast 
model and a 1.4% decrease when combined with the MacCannell et al. ventricular 
fibroblast model. Thus, effects on M-F coupling on APD in the remodelled myocytes 
were incremental. ERP was similarly overwhelmed by ionic remodelling with M-F 
coupling only providing incremental changes.  
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Figure 22. Comparison of the effects of fibroblast coupling and ionic remodelling and 
heterogeneity. A: APD90 differences for the developed M-F model (green), ionic remodelling 
(IR, red) and both combined (IR atr, cyan). B:  APD90 differences between different region, 
with and without M-F coupling. Blue shows right atrial tissue and RAA tissue, solid lines are 
the uncoupled CRN model and dashed show the atrial M-F coupled model. 
Utilising the regional heterogeneity developed by Colman et al.39 the effects that 
the new fibroblast coupling model had on the regional ionic heterogeneity were 
analysed (Figure 22). The model had a negligible effect on heterogeneity in the right 
atrium.  
Conduction velocity was investigated in 1D (Figure 23A), due to its contribution to 
arrhythmogenesis.  Both M-F coupling models reduced the conduction velocity 
compared to the control but the ventricular M-F model had the greater effect. This 
can be explained by the longer ERP in the latter case (Figure 18B). The peak INa was 
investigated, in order to find a mechanism for the differences in conduction velocity 
(Figure 23B).  






































Figure 23. Conduction velocity and maximum INa for different M-F coupling models. A: 
shows the conduction velocity restitution, and B shows the restitution of the peak sodium 
current for the various coupling conditions. Coupling with the ventricular fibroblast model 
(red) resulted in a greater reduction in conduction velocity than that with the atrial 
fibroblast model (green), as compared to the uncoupled CRN myocyte model (blue).  
The M-F coupling models had reduced current magnitudes compared to the 
uncoupled CRN model, with the smallest INa seen due to coupling with atrial 
fibroblasts at high pacing rates. This can be explained by the more positive RMP in 
atrial fibroblasts (Figure 17B), resulting in a stronger electrotonic M-F current, IGap 
(Figure 17E and F) and partial inactivation of INa. Shorter ERP and higher CV in this 
case (compared to the M-F coupling with ventricular fibroblast) may be explained 
by a better balance between the reduction of INa and increase of IGap (see below).  
3.4. Discussion 
A novel model was developed for the atrial fibroblast, which is more relevant to 
atrial electrophysiology than the existing ventricular fibroblast models and gives 
insight into the arrhythmogenic effects of M-F coupling in the atria. The model 
simulations illustrate the effects of M-F coupling on atrial electrical properties are 































































more subtle than the ventricular fibroblast model. M-F coupling increases the RMP 
of the myocyte, which effectively reduces the excitation threshold. This behaviour 
can be responsible for regional conduction block and may contribute to atrial 
arrhythmogenesis, for example by facilitating re-entrant wave propagation. 
Therefore, the model of atrial fibroblast and M-F coupling provides a valuable tool 
for studying arrhythmogenic mechanisms for AF, and the models will be integrated 
into a 3D human atrial model in the further chapters of this study.   
3.4.1. Effects of the M-F coupling  
Previous studies have shown that changes in RMP of the fibroblast have significant 
effects on the electrophysiological properties of the myocyte coupled to it56,92,95. 
Models that  present a more negative fibroblast RMP, such as MacCannell et al., 
require high levels of M-F coupling and gap junction conductance (up to 30 
fibroblasts and 138nS)95, which is far higher than has been recorded in vitro.   
During the early phases of AP, the fibroblast in the M-F model acts as a current sink 
effectively reducing the upstroke of the myocyte, with the APA being reduced by 
5mV in the atrial fibroblast model (Figure 19A). This behaviour has been shown in 
other studies 56,92,93 but with larger coupling  conductances. The reduction in APA 
could slow down the propagation in the tissue due to the reduced current 
transferred to neighbouring cells. During the later phases of the AP, the fibroblast in 
the M-F model acts as a current source, prolonging the repolarisation phase and 
increasing the ERP (Figure 18B). This is a similar finding to that by Maleckar et al. 
and Jacquemet et al 92,93, both studies used a modified MacCannell et al. model 
76 
 
with a higher fibroblast RMP (-31.4mV) based on data at the upper limit of the 
experimentally reported physiological range81,88.  
The excitation threshold decrease in the model of a myocyte coupled to fibroblasts 
is due to the increase in the myocyte RMP (caused by inflowing IGap) because of the 
relatively higher RMP of the fibroblasts. This can be observed in Figure 21B: which 
demonstrates that when the number of coupled fibroblasts is increased the 
excitation threshold is reduced. 
During the RMP phase, fibroblasts act as a current source for the myocyte, which 
may also contribute to the reduction in APA and CV due to a partial inactivation of 
INa (Figure 23B) Differences between CV, ERP and excitation threshold between the 
M-F coupling models with ventricular and atrial fibroblasts may be explained by a 
rate-dependent balance between the increase of IGap due to the M-F differences in 
RMP and the resultant decrease of INa. 
Fibrosis has varying distributions within tissue for different disease phenotypes. 
One of these phenotypes is regional fibrosis known as patchy fibrosis. In this 
condition there is an observable increase in fibrosis density confined to specific 
locations throughout the organ. In these regions, changes in ERP and CV 
heterogeneity due to increased M-F coupling could lead to wave break and 
initiation of AF. Note that structural discontinuity of the tissue caused by fibrosis 
can also cause a stable rotor to break down into multiple wavelets. This is a 
behaviour more akin to AF; which will be discussed in further chapters.  
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3.4.2. Comparison between atrial and ventricular fibroblast models 
The MacCannell et al. model of ventricular fibroblast and its variants is the most 
detailed existing fibroblast model, which is why it has been  used it as a benchmark 
for the atrial model. M-F coupling parameters in the atrial model were set at lower 
level (0.5pS) than in the MacCannell et al. study93, which corresponds better to 
experimental observations of a small number and extent of M-F couplings. 
The RMP of an uncoupled atrial fibroblast in the model was -42mV, which was more 
positive than that in the MacCannell et al. ventricular fibroblast model (-47mV) and 
other  ventricular models93–95. This is more representative of atrial physiology 
(Table 2)93. The atrial M-F coupling model also produced lower excitation 
thresholds and lower ERP, and as a result higher CV, than the MacCannell et al. 
model. Substantially shorter ERP and higher CV in the atrial M-F model may be 
explained by a better balance between the reduction of INa and increase of IGap 
(Figure 23).  Using the atrial fibroblast model instead of the existing ventricular 
fibroblast model in 3D human atrial modelling could lead to vastly different 
behaviour, which is discussed in chapter.4.  
3.4.3. Effects of ionic remodelling and heterogeneity 
Ionic remodelling is strongly linked with AF progression and has been observed in 
both animal and human studies of AF. This type of remodelling leads to a large 
reduction of APD and ERP, which has previously been modelled in great detail and 
has been found to be arrhythmogenic.42 When M-F coupling was combined with 
ionic remodelling, the additional effects on the APD and ERP in a single myocyte 
were incremental. The results show that compared to ionic remodelling, M-F 
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coupling has an insignificant effect suggesting that diffuse fibrosis may not be a 
mechanism for AF maintenance. Fibrosis can be induced rapidly as a pathology of 
other disorders (such as heart failure) or incrementally with age. In combination 
with the structural effects of fibrosis, may provide substrate for AF initiation. This 
will be further investigated in Chapter 5.  
Electrophysiological heterogeneity of the atria has been linked to the AF genesis, as 
it can lead to wave breakdown and complex wave dynamics38. M-F coupling in the 
atrial model did not lead to significantly increased heterogeneity in the right atria. 
However, effects on atrial heterogeneity associated with patchy fibrosis can be 
more substantial (Chapter 5). 
3.4.4. Limitations 
The major limitation of this work is a lack of experimental validation for the 
electrophysiological effects of fibrosis at the cell level, such as changes in APD and 
ERP. However, the same lack of data highlights the importance of modelling and 
simulation in order to better understand the problem. Further experimental 
measurements in-vivo are required for the validation of the M-F coupling effects 
observed in the models. 
3.4.5. Conclusion 
In conclusion, the M-F coupling model with atrial fibroblasts had more modest 
electrophysiological effects on APD and ERP than ventricular fibroblast models.  
However, it presented different arrhythmogenic properties, primarily through the 
relatively high RMP in atrial fibroblasts, and as a result, reduced myocyte 
excitability and conduction velocity in atrial tissue. The utilization of more 
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comprehensive experimental data for the novel atrial fibroblast model, compared  
to the existing models for ventricular fibroblasts, make it more representative of 




4. 3D human atrial model  
4.1. Introduction  
AF is a complex condition that requires better understanding, from cellular to 
whole organ level. This is evident from the difficulty of treating the disorder 
clinically after decades of extensive research. Both drug therapy and catheter 
ablation have low long-term effectiveness, which may be due to the lack of 
mechanistic understanding of the treatment beyond the cellular electrophysiology 
level and the nature of ablated tissue substrate.   
4.1.1. Atrial structural effects 
Various structural factors that may affect AF arise from the complexity of atrial 
geometry; such as shape, wall thickness and curvature, complex fibre arrangement, 
AF-induced remodelling and the development of heterogeneous fibrosis. They have 
all been shown38,97–99 to influence the propagation of excitation waves through the 
atria. The individual effects of these factors on arrhythmogenesis are hard to 
explicitly quantify and they may act cumulatively.   
Atrial shape is an indicator for recurrence of post ablation AF100 and may have 
functional effects that promote AF. This may be a result of the curvature of the 
atrial walls, which can be highly convoluted, especially around the PVs and within 
the atrial appendages. It has been shown in biophysical simulations that wavefront 
curvature can effect conduction velocity and promote vortex shedding and initiate 
re-entrant waves.101 Moreover, the surface curvature can result in the drift of re-
entrant rotors, and hence play a role in their ultimate location in the atria97. The 
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knowledge of such locations is important during ablation that targets the rotors 
sustaining AF. Changes in the atrial wall thickness have also been shown to 
generate re-entry and subsequent rotor drifts.102 The potential mechanism of these 
phenomena is source-sink mismatch due to irregular geometrical features, such as 
wall thickness gradients.40,103 
The myocardium, like all muscle is comprised of fibres that allow for efficient 
transmission of electrical signals and to aid tissue contraction. The consequence of 
the tissues electrophysiological properties is anisotropic conduction. Propagation 
along the fibre is accelerated by the predominantly longitudinal coupling of the 
cells. The majority of gap junctions are localised at the distal ends of elongated 
atrial myocytes. Fast conduction is particularly important in larger bundles such as 
the CT and BB, which carry the electrical excitation waves from the SAN to the 
ventricles and the LA, respectively. The overall structure of fibres throughout the 
organ determine the conduction pattern for the waves99 and therefore can 
drastically influences arrhythmogenesis.51,104  
Further to complex and variable fibre arrangements throughout the atria, atrial 
tissue is transmurally inhomogeneous and can possess distinct, layers of tissue. This 
is most notable in the RA,105 where the large fibrous pectinate muscles have a 
distinct difference in fibre orientation and structure to that of the adjacent smother 
myocardium. A major difficulty in studying atrial fibre structure is the thinness of 
the atrial wall which makes conventional imaging methods difficult (Chapter 6). A 
recent successful reconstruction of the fibre orientation in ex-vivo canine atria was 
based on the application of a novel micro-CT technique106. However there are 
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significant physiological differences between species making this dataset not 
directly applicable for human atrial modelling. Recent human models have used 
rule-based fibre orientation based on ex-vivo knowledge (discussed in this chapter). 
On the functional level, the local atrial geometry, fibre orientation and source-to-
sink mismatches all translate into the conduction velocity (CV) of electrical waves. 
Changes in CV and CV heterogeneities have been linked to arrhythmogenesis.107–
109,110  
4.1.2. Structural effects of fibrosis 
As discussed in Chapter.2, fibrosis has substantial structural (through interstitial 
depositions of collagen) and electrophysiological (through M-F coupling) effects on 
atrial tissue. However, structural remodelling due to depositions of collagen itself 
also affects the tissues electrophysiological properties, such as the conduction 
velocity and anisotropy. It has been shown that increased fibrosis levels are 
associated with slower conduction in atrial tissue111,112. A possible contribution to 
this is the increasing separation of fibres and the down-regulation of Cx43 
associated with fibrosis113.  Fibrosis also has a profound effect on the anisotropy of 
the tissue, due to the predominantly lateral collagen depositions in interstitial 
fibrosis. Thus, anisotropy is increased with fibrosis which has been measured in 
tissue (see Table 4, page 83)81,114. Additionally, tissue anisotropy may be increased 
by compensatory gap junction remodelling, which results in the lateralisation of 
Cx40 and Cx43 expression in response to the reduced lateral conduction caused by 





Table 4. Anisotropy ratios measured in experiments and used in existing models.  
4.1.3. Investigating cardiac electrophysiology  
Clinical electrophysiology studies, such as body surface mapping and catheter based 
endocardial activation mapping cannot account for the unique structural factors 









Aslanidi et al. 38 ~1.9  10 Sinus Rhythm Human 
Tobon et al.  115 - 1- 9 Sinus Rhythm Human (LA  - CT) 
Seeman et al. 116 - 1-9  Sinus Rhythm Human (LA - CT) 
Krueger et al.  117 - 1-23.25 Sinus Rhythm Human (LA - PM) 
Harrild et al. 118 - 7.5 Sinus Rhythm Human 









Yamamoto et al.119 1.4 - Sinus Rhythm Rabbit (SAN) 
Liu et al.  120 1.95 - Atrial Flutter Human 
Hansson et al.121 1.14 - 1.8  - Sinus Rhythm Human (CT) 
Kleber et al.  122 2.1 , 10 - Sinus Rhythm Human (RA,CT) 
Koura et al.  123 1 - 1.42   - Aging  Dog (young - old) 
Verheule et al.  124 1.8 - 4.5  - AF and Fibrosis Goat 
Krul et al. 114 1.05–13.4  - AF  Human (LAA) 
Angel et al. 125 1.47 - 1.72  - AF Goat  
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with a pre-scanned detailed 3D image. Although this is possible in AF patients, 
registration of these images is difficult to implement. Both clinical mapping and 
current imaging methods have too low resolution to provide detailed information 
and elucidate any mechanistic links between the structure and function in AF. 
Computation modelling has been applied to dissect 3D electrophysiological 
dynamics in situations when clinical and experimental methods fail to provide 
detailed insights.  
Early 3D models relied on simplified geometries126 or small-scale geometries (like 
the pectinate muscles104) but as computational power has increased; models have 
become more detailed and focused toward patient specificity. The older models 
showed the importance of increased biophysiological detail, as more complex 
behaviours could be investigated. Recent atrial models focused on enhancing 
biophysical details such as: patient specific geometries, fibre orientation115,117,127, 
fibrosis98 and regional electrophysiological heterogeneity69. There is a need for 
integration of all of these factors into a comprehensive modelling framework to 
investigate the amalgamated effects.  
The aim of this work is to incorporate the atrial model for M-F coupling with a 3D 
human atrial model that accounts for details of atrial structure, regional 
heterogeneity and anisotropy, to investigate the arising arrhythmogenic effects. 
The next section describes how the biophysically detailed 3D atrial model was 
created.  The rest of this chapter will focus on simulations of effects of uniform 
diffuse fibrosis in the 3D atria. The next chapter will apply similar models to explore 




4.2.1. Atrial geometry and fibre orientation 
To provide the anatomical structure of the atria for simulations, a 3D volumetric 
geometry is required. The "Visible Human Project" is a collection of anatomical 
datasets created by the US National Library of Medicine. Ex-vivo images were 
created by cryo-sectioning an entire cadaver; photographs of each section were 
taken and digitised.  
Figure 24. Atrial geometry model based on the Visible Female dataset. A and B show the 
segmented regions of the atria, and C and D show fibre orientations; A and C are posterior 
views whereas B and D are transverse views. The segmented and labelled anatomically 
distinctive regions are, 1=LA, 2=PV, 3=LAA, 4=BB, 5=AV valve, 6=RA, 7=CT, 8=PM, 9=RAA, 
10=AS (not shown) and 11=SAN. The colours in panels C and D illustrate the magnitude of 
the X axis component of the fibre orientation vector. The dataset has a 0.33mm resolution  
A                                  B 
C                                  D 
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Regions of interest, such as the 3D atria, were later segmented and reconstructed 
(Figure 24A and B). The specific 3D atrial geometry used in the present study was 
from the “Visible Human Female” dataset. The segmented atrial geometry was 
developed by a collaborating group at the Karlsruhe Institute of Technology5 and 
was used as the geometric basis for the biophysical model.  
Although this dataset cannot be said to be patient specific, it was the most detailed 
human atrial dataset available when building the model. The fibres were developed 
using an algorithmic approach to create a vector field of aligned fibres based upon 
landmarks observed in ex-vivo anatomical studies of human atria117. 
Some post processing was required to efficiently integrate the fibre dataset into the 
model. Since the rule-based fibre orientation was introduced region-by-region, the 
original dataset had discontinuities at borders between such regions. These 
discontinuities resulted in numerical instabilities during simulations. In these areas 
a smoothing filter was applied. The filter was a 5 voxel neighbourhood mean filter 
masked by the 3D geometry.  
4.2.2. 3D whole atria model 
The single cell models used in this work, discussed in chapters 2 and 3, were 
incorporated into a framework that included atrial geometric shape, fibre 
orientation and segmentation of electrophysiologically distinctive regions. Regional 
electrophysiology models described in Chapter 2 were allocated to the relevant 
segmented region (Figure 24A and B).   
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The mathematical model (equation 10) used to simulate 3D atria is described in 
section.2.4.2. The model was solved numerically using the explicit forward method, 
with the dataset resolution of 0.33mm voxels used as the spatial step of numerical 
integration and a time step of 0.005ms. Although the spatial step was determined 
by the geometry dataset, both the space and time steps were varied to check to a 
basic convergence of the results. During simulations described in this section, 
components of the diffusion tensor (D) were varied. Thus, by reducing the 
longitudinal and transverse diffusion coefficients (see below), AF-induced tissue 
remodelling and some aspects of fibrotic conditions could be simulated.  
AF was initiated by fast pacing in the 3D atria model.42 To reduce computational 
time, initial conditions for all variables were obtained by simulating steadily paced 
single cell models prior to the 3D atria simulation. The single cell model for each 
region was paced 30 times at a given BCL, and the values for all variables were 
saved to a .txt file, to be used as an input by the 3D atrial model. Finally, the 3D 
model was paced between 3-10 times (dependent on the conditions) at the same 
BCL to initiate AF.  
Re-entry was initiated in the model through fast pacing in the RAA, allowing for the 
wave to propagate perpendicularly to the cristae terminalis to maximise the chance 
of wave block. This may not be physiologically accurate as ectopic beats most 
commonly originate from the PVs128. However RA ectopic foci have been observed 
in a significant number of patients, as well as in-vivo experiments129. This method of 
AF initiation has been applied before in computational atrial models.38,39  
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The model uses the 3D fibre vector array (Figure 24C and D) to calculate the 
diffusion tensor to each voxel dependant on the orientation of the fibre.130  This 
calculation also requires the longitudinal and transverse diffusion coefficients, DL 
and DT, where DL was constant at 0.3 mm
2/ms and DT was varied as described 
below.  
The complex geometric shape of the atria makes applying boundary conditions non-
trivial. A boundary layer surrounding the outer surfaces (both epicardial and 
endocardial) is created based on calculating the surface normals for each voxel and 
applying the Neumann zero-flux boundary conditions along the normals35. This 
ensures that zero flux is maintained between the atrial surface and the respective 
boundary layer.   
4.2.3. Simulated Conditions 
The model settings were varied to simulate different conditions linked to fibrosis 
and AF (Table 5). Three levels of structural remodelling were developed to simulate 
different types of fibrosis. (1) Control, simulated with no structural remodelling-
associated changes, where diffusion coefficients and anisotropy parameters 
simulate ‘healthy’ atrial tissue. (2) Diffuse fibrosis, with uniformly decreased 
diffusion coefficients simulating decreased levels of intercellular coupling 
associated with AF. (3) Interstitial fibrosis, simulated with increased anisotropy 
associated with high level of collagenous infiltration in long-term AF. In addition to 
these three conditions, variations of electrophysiological parameters associated 
with AF were also investigated; M-F coupling (both with atrial and ventricular 
fibroblasts) and ionic remodelling.  
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Normal structural conditions were validated by comparing activation times 
simulated in the 3D atria model during sinus rhythm (SR), with the respective 
clinical measurements (Table 5 and Figure 25). Activation times were measured at 
various anatomically distinctive locations in both atria and were found to be within 
clinically reported data ranges. This provided a validation for the choice of DL = 0.3 
mm2/ms, as well as the variation of anisotropy ratio, DL/DT, from 10:1 to 16:1. 
 
Table 5. Arrival times in the 3D atrial model, compared to clinical findings by Lemery et al. 
131  
 Diffusion coefficient (DL) 
( mm2 ms-1) 
0.3  0.3   0.12   0.12   Clinical data by 
Lemery et al. 131 
Anisotropy ratio (DL/DT) 10:1 16:1 10:1 16:1  
Arrival times (ms)           
1st SVC <10 <10 <10 <10 26 ± 22 
1st RUPV 40 50 80 80 75 ± 24 
1st IVC 60 70 110 120 88 ± 33 
Latest IVC 80 90 150 160 - 
Latest RA 90 100 180 190 93 ± 17 
1st LIPV 80 90 150 160 101 ± 23 




For simulations of the diffuse fibrosis condition, a 60% reduction in the diffusion 
coefficient DL was applied, while the anisotropy ratio was maintained at 10:1. For 
simulations of the more severe interstitial fibrosis condition, an additional increase 
of the anisotropy ratio from 10:1 to 16:1 was applied. 
 
Figure 25 Sinus rhythm activation maps simulated with the 3D atrial models for four 
different conditions. Left panels (A and C) show the low anisotropy (DL/DT =10:1) model and 
the right (B and D) show high anisotropy (DL/DT =16:1). A and B show control conditions 
with standard diffusion coefficient (DL=0.3 mm
2/ms) and C and D show fibrotic conditions 
with the reduced diffusion coefficient (DL=0.12 mm
2/ms). Region-specific activation times 
for the four conditions are compared to the respective experimental data in Table 5. 
A                         B 
C                         D 
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In all structural remodelling conditions additional effects of M-F coupling, using 
either atrial or ventricular fibroblasts, were investigated. As with the single cell 
modelling presented in Chapter.3, both regional heterogeneity and ionic 
remodelling were also considered. 
4.2.4. Visualisation of results 
The 3D propagation results are displayed either as snapshots of voltage iso-
contours at successive moments of time or as full activation maps over a period of 
time (which is 250 ms, unless otherwise stated). The former is displayed using a 
non-linear rainbow colour scheme for the voltage iso-values ranging from -60 to 
+30mV. The snapshots were selected at different intervals of time to clearly show 
different behaviours. This was necessary because propagation phenomena, such as 
wave block or re-entry, rarely occurred at the same moments of time between 
simulated conditions. For the activation maps, the activation time is measured as 
the earliest time at which the voltage exceeds the threshold value of -40mV, the 
resulting activation maps were displayed using a linear rainbow colour scheme.  
4.3. Results 
4.3.1 Sinus Rhythm Activations 
The atrial activation sequences simulated with the 3D model during SR stimulations 
at BCL of 300ms are shown in Figure 25. In simulations with a 'healthy' anisotropy 
ratio of 10:1 (Figure 25A and C), the wavefront was marginally more regular and the 
longitudinal activation along the CT was 10ms faster than in simulations with higher 
anisotropy of 16:1 (Figure 25B and D). Conduction velocity field in all possible 3D 






Table 6. Re-entry type and duration of 3D simulations. Re-entrant behaviour was 
considered sustained (similar to sustained AF) if it lasted for the entire duration of the 
simulation, which was 12 seconds. 
The higher anisotropy ratio of 16:1 enabled a better agreement of the simulation 
results with the clinical data by Lemery et al. (Table 5). This can be explained by the 
fact that the data was obtained from AF patients (although in sinus rhythm), and 
hence their atria can be better characterised by an 'unhealthy' set of parameters. 
Note that even in simulations with faster pacing rates (BCL of 260ms, which is closer 
to rates observed in AF), little difference was observed in wave pattern or 




No structural remodelling 
  
Control Unstable re-entry 1800 
M-F coupling  
(atrial fibroblast) 
Unstable re-entry 3480 
Diffuse fibrosis    
 Control Unstable re-entry 3400 
M-F coupling 
(atrial fibroblast) 
Unstable re-entry 2690 
M-F coupling 
(ventricular fibroblast) 
Unstable re-entry 11720 
Ionic remodelling Stable rotor Sustained 
Interstitial fibrosis   
Control Re-entry followed 





by wave breakdown 
Sustained  
   
93 
 
morphology between high and low anisotropy (not shown), with only small 
reductions (10-30ms) in activation times.  
Figure 26. Simulations of the 3D atria without structural remodelling, showing wave block 
and re-entry. A and C show two successive voltage snapshots in control (no M-F coupling), 
whereas B and D show the snapshots for the condition of M-F coupling (atrial fibroblast 
model) discussed in Chapter.3. Wave-block lines are indicated by the white line in A and B; 
wave direction is indicated by the black arrows. The time differences between A-C and B-D 
are not equal; the figures were chosen to best illustrate the re-entrant behaviour. The re-
entry in these simulations was unstable and self-terminating.  
Reducing the diffusion coefficient DL (Figure 25C and D) for the diffuse fibrosis 
condition has a significant effect on the wavefront propagation. The total atrial 
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activation time was reduced by 50-70ms (referring to the latest activations in the 
RA and LA in Table 6). This substantial activation time reduction was in addition to 
the smaller reduction (10ms) due to high anisotropy (Figure 25D). Hence, the 
interstitial fibrosis condition, which combined decreased DL and increased 
anisotropy, was characterised by longest activation times (190-200ms) (Table 5). 
4.3.2 Re-entrant Activations 
Fast pacing in the anterior RA at a BCL of 235-260ms (dependant on conditions) 
resulted in a conduction block leading to wave breaks and re-entry in all simulated 
conditions (Figure 26, Figure 29 and Table 6). The conditions included both the 
structural changes, considered above (increased anisotropy and decreased diffusive 
coupling, associated with interstitial and diffuse fibrosis during AF) and the 
electrophysiological conditions described in Chapter 3 (control, M-F coupling using 
either atrial or ventricular fibroblast models or ionic remodelling). 
 Figure 26 shows ‘healthy’ tissue with no structural remodelling and M-F coupling 
effects. Figure 27 illustrates the effects of diffuse fibrosis with and without ionic 
remodelling and Figure 28 demonstrates the effects of diffuse fibrosis and M-F 
coupling of atrial and ventricular fibroblasts. Figure 29 shows the effects of 
interstitial fibrosis and M-F coupling. Table 6 summarises the behaviours of these 
simulations.  
The precise location and timing of the wave-block varied depending on the 
condition considered and pacing rate used, but was always clearly observed 




Figure 27. Simulations of the 3D atria model with fibrosis related structural remodelling and 
ionic remodelling (IR). This includes normal anisotropy and diffusion coefficient reduction. 
Panels A and C indicate control simulations with no electrophysiological alterations and the 
right (B and D) show those with ionic remodelling. The top row (A and B) show incidence of 
wave block (white lines) in the simulations and C and D show re-entry formation. Wave 
direction is indicated by the black arrows. The unstable wave seen in Figure 27A and C (A 
and C here) was not seen with ionic remodelling, rather a stable rotor was present (D).  
The extent of the wave block also greatly varied between conditions, for example as 
shown in Figure 27A and B for diffuse fibrosis with and without additional ionic 






Figure 28. Simulations of the 3D atria model with fibrosis related structural remodelling and 
M-F coupling. This includes normal anisotropy and diffusion coefficient reduction. Panels A 
and C indicate simulations with the developed atrial M-F coupling model and the right (B 
and D) show those with the MacCannell et al. ventricular fibroblast model. The top row (A 
and B) show incidence of wave block (white lines) in the simulations and C and D show re-
entry formation. Wave direction is indicated by the black arrows. These simulations also 
showed unstable self-terminating re-entry. The nature of this behaviour was similar 
(although not visually identical) to that seen in Figure 27. 
initially formed two re-entrant waves (for example Figure 27A and B) persistent for 
a short duration of less than 3 periods.  After this, one terminated and the other 
continued to propagate (for example Figure 27C and D). Self-termination of one 
from a pair of rotors can be explained by the asymmetry of conduction.   
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The re-entrant dynamics in both cases of no structural remodelling and diffuse 
fibrosis was characterised by a single self-terminating wave. This travelled through 
the atria with no apparent pattern or rotor focal point. The instability of this 
behaviour due to the long wavelength (when compared to ionic remodelling) meant 
that the wave would eventually travel to an area where re-entry was not possible, 
such as tissue near valve isthmuses or large vessels, and would self-terminate.  
The duration of re-entry (Table 6) was also varied between different conditions. In 
all conditions with no structural remodelling (shown in Figure 26) and diffuse 
fibrosis (Figure 27C and Figure 28C and D) re-entry was self-terminating. The 
duration of re-entry before its self-termination was generally longer with diffuse 
fibrosis and M-F coupling (particularly with the ventricular fibroblast model) (Table 
6). Only in conditions of ionic remodelling in addition to diffuse fibrosis (Figure 27B 
and D) was a stable rotor generated and sustained for the entire duration of 
simulation. In conditions of high anisotropy associated with interstitial fibrosis 
(Figure 29), stable rotors and secondary multiple wavelets persisted after 20s of 
simulation similar to sustained AF.  
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Figure 29. Simulations of the 3D atria model with structural remodelling linked with AF-
induced interstitial fibrosis. The latter includes both increased anisotropy and reduced 
diffusion coefficient. Left panels (A, C and E) show successive voltage snapshots in control 
(no M-F coupling) and the right panels (B,D and F) show the snapshots for the condition of 
M-F coupling (atrial fibroblast model). A and B show the initial wave blocks (white lines), 
and C and D show the re-entrant behaviour (long black arrows). E and F show multiple, 
independent wavelets indicated by the short black arrows.  
Control    M-F 











E     F 
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Re-entrant behaviour was induced by rapid pacing in all conditions but with 
different pacing frequencies, which reflect different ERPs in those conditions 
(Chapter 3). Different re-entrant dynamics observed were also linked with the 
variations of ERP, as well as CV, between those conditions (see details in 
Discussion). In most simulations with low anisotropy, only a single short-duration 
re-entrant wave was present (Figure 30B), with the only exception of ionic 
remodelling. Longer duration of re-entry between these conditions (Table 6) 
correlated with either shorter ERP (due to M-F coupling) or lower CV (due to diffuse 
fibrosis), both leading to a shorter wavelength. Ionic remodelling resulted in the 
shortest wavelength, and hence produced a stable rotor (Figure 30A). The 
mechanism for self-termination appeared to be the increased wavelength and 
larger extent of rotor meandering of the CRN compared to the ionic remodelled 
version. In these cases, the rotor easily reaches an edge or structural boundary and 
terminates due to the majority of atrial tissue being insufficiently repolarised.  
Another pattern was observed in high anisotropy conditions linked with interstitial 
fibrosis. A dominant rotor was initiated due to the overall reduction of wavelength 
which broke down into a series of secondary wavelets (Figure 30C), with a general 
pattern of multiple wavelets propagating chaotically and independently, which is 
typical of clinical AF. Each wavelet lasted 50-200ms before being intersected by 
another wave. The complexity was not uniform as the number of waves varied 
throughout the simulation. In these simulations there was no evidence of a stable 
rotor. Diffuse fibrosis resulted in activation patterns with an intermediate level of 





Figure 30.  Activation maps in the 3D atria model for typical patterns of observed re-entrant 
behaviours. A, shows a stable rotor, seen in the conditions with ionic remodelling. B, 
illustrates an unstable re-entrant wave in the conditions with diffuse fibrosis and C shows 
wave-breakdown in the conditions with interstitial fibrosis. Wave propagation directions 
are shown by the black arrows and wave-blocks are shown by the white lines. In B and C, 
the left atrium is fully activated at the initial moment of time t=0 and the PVs are 
repolarised and not activated (and hence, seen in the transparent blue colour corresponding 
to the tissue geometry) within the time range of these activation times.  
4.4. Discussion  
The complexity of atrial structure and function, and their remodelling during AF, 
results in complex electrophysiological dynamics which cannot be adequately 
described by ex-vivo cell-to-tissue level studies or voltage mapping in patients, 
largely due to the unknown structure-function relationships. The 3D atria modelling 
enables the linking of atrial structure and function and allows the exploration of 
cell-to-organ AF mechanisms in-silico. Simulations of a novel 3D human atria model 
presented in this chapter show a range of re-entrant behaviours caused by various 
pathophysiological conditions associated with AF-induced fibrotic remodelling.   
A         B       C 
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4.4.1. Validation of diffusion coefficients 
Initially, the model was validated against clinical atrial activation data obtained in 
sinus rhythm. The simulated SR activation maps showed the archetypal elongation 
of the wavefront extending along the CT, which has been observed in-vivo.132 The 
arrival times were comparable to clinical measurement by Lemery et al.131 (see 
Table 5, page 89), with the exception of the first SVC activation. This was due to the 
segmentation of the SAN being too high on the CT (Figure 24)69 in this particular 
geometry. The close match between activation times simulated and those found 
clinically validates the choice of parameters (diffusion coefficients) in the models. 
We also considered activations emanating from the entire SAN simultaneously, 
whereas in reality this process is not instantaneous and propagation inside the SAN 
is relatively slow. Besides, due to variation in atrial size and shape there is an 
inherent variation in activation times. Nevertheless, the simulation results are 
within the range of variability of the clinical data, with the best agreement found 
for the case of 16:1 anisotropy (Table 5).  
4.4.2. 3D atrial simulations 
Simulations of the 3D atrial model with no structural remodelling, i.e. without 
increased anisotropy and normal diffusion coefficients, produced unstable re-entry 
for a short duration. This was due to the fact that both ERP and CV in these 
conditions were relatively high (Chapter 3), resulting in a long wavelength 
comparable to the size of the atria. This behaviour was repeated in diffuse fibrosis 
simulations where the diffusion coefficients were decreased, but with re-entry 
duration increased as a result of decreased CV.   
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Curiously, the combination of atrial M-F coupling with diffuse fibrosis (diffusion 
coefficient reduction) resulted in slightly decreased AF duration in the 3D atria 
model, in contrast to other conditions associated with fibrosis. This may be due to 
the biphasic relationship between the ERP restitution curves with/without the M-F 
coupling (Chapter 3, Figure 19). The respective combination of diffuse fibrosis with 
M-F coupling using the ventricular fibroblast model resulted in a much longer 
duration of re-entry. This could be due to the reduction in wavelength associated 
with this model shown in Chapter 3. This is evidenced by a larger excitable gap 
(between a re-entering wave and the preceding one) seen in the case of coupling 
with ventricular fibroblasts (Figure 24E) as compared to that with atrial fibroblasts 
(Figure 24C). These results also point the sensitivity of 3D atrial behaviour to the 
choice of a fibroblast model. The atrial fibroblast model developed in this study, 
based on more comprehensive data is more representative of atrial 
electrophysiology.  
In future studies with larger numbers of subjects, the expected outcome would be a 
typical rotor stabilisation in the border zone. This is primarily due to the reduction 
of conduction velocity in these regions and the stabilising effect on rotor dynamics. 
4.4.3. Ionic remodelling  
Another outstanding observation was related to ionic remodelling, which 
predictably produced stable re-entry due to the much shorter wavelength (see 
Figure 30). Although the duration of this simulation was longer (Table 6) it failed to 
break down and only produced stable rotors. This may indicate that ionic 
remodelling and fibrosis distribution have different roles in AF progression. Fibrosis 
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due to AF requires sustained AF episodes for several months before noticeable 
collagen deposition is observed. This suggests that fibrosis may have more impact 
in the later stages of AF progression.  
4.4.4. Interstitial fibrosis 
Increased anisotropy was investigated as a property of interstitial fibrosis. During SR 
simulations little difference was observed between different levels of anisotropy, 
aside from slight conduction slowing during fast pacing. This suggests that under 
normal conditions higher anisotropy may not have a substantial effect on the 3D 
atrial dynamics. This is in contrast to behaviours during fast pacing and resultant AF, 
where conduction block and wave breakdown is more prevalent in higher 
anisotropy conditions. This was the only condition where the 3D atria model 
produced a sustained re-entry and AF-like patterns. The latter were present as a 
single re-entrant wave followed by breakdown into multiple re-entrant wavelets. 
Overall, the 3D wave dynamics changes due to increased anisotropy were more 
significant than the effects of M-F coupling or wavelength reduction due to ionic 
remodelling. This may suggest that the structural effects of fibrosis, which develop 
later in AF progression, may play an important role in AF stabilisation rather than 
initiation.  
4.4.5. Conclusions 
In conclusion, the model showed that anisotropy linked with AF-induced interstitial 
fibrosis was the primary cause for wave breakdown, which best represents AF 
behaviour. Diffuse fibrosis resulting in reduced electrotonic coupling between atrial 
myocytes, as well as M-F coupling with atrial fibroblast, played a significant but less 
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prominent role than increase anisotropy. However, stabilisation of sustained 
activity in specific atrial locations, which is a theoretical mechanism of AF133,134, was 
not observed in any of the multiple conditions considered in this chapter. Such a 
stabilisation has been increasingly linked with the presence of heterogeneous 
fibrosis distributions in the atria. In the next chapter, patient-specific areas of 
patchy fibrosis are mapped onto the atria model to investigate a possibility of rotor 







5. Patient-specific fibrosis modelling 
5.1. Introduction 
Patchy, or compact fibrosis has long been suggested as a mechanism for 
arrhythmogenesis. Structural and functional tissue heterogeneities associated with 
fibrosis have generally been linked to arrhythmogenesis135. Furthermore, 
histological studies have shown fibrosis distributions to be non-uniform in the 
atria136 and ventricles137. These distributions can be presented as large collagen 
deposits within the functional myocardium. In addition to impairing the 
myocardium contractility, fibrotic tissue is electrically unexcitable. Hence, 
interstitial depositions of fibrosis can slow down or block the propagation of 
electrical excitation waves, creating conditions for the generation and sustenance 
of re-entrant propagation. In ventricular tissue, heterogeneous non-functional 
myocardium caused by infarction has been shown to be directly pro-
arrhythmogenic50. However, the effects of patchy fibrosis in the context of AF have 
not yet been studied in detail, which may be due to the difficulty of linking 
structural (e.g., via histology) fibrosis data and measured heterogeneous electrical 
activity.  
Recently, atrial fibrosis has emerged as one of the most promising clinical markers 
for AF, which strongly correlates with improved treatment effectiness138. It has also 
been shown that atrial fibrosis is higher in AF patients compared to healthy subjects 
and correlates positively with AF recurrence139 after ablation.  Furthermore, direct 
ablation of fibrotic areas identified from late-gadolinium enhanced MRI8,140 or 
electro-anatomical mapping9 can significantly improve the therapy success rates.  
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This suggests that patient-specific distributions of atrial fibrosis may directly or 
indirectly determine the dynamics of electrical drivers sustaining AF. Better 
knowledge of the location of fibrotic areas has a potential to increase the 
knowledge of AF genesis and provide important assistance for catheter ablation 
therapy.  
This chapter explores missing links between patchy fibrosis and AF using patient-
specific models of the 3D human atria. It also aims to highlight potential sensitivity 
to methodology used during the quantification of atrial fibrosis. For the duration of 
this work, ‘patchy’ fibrosis will refer to regions of inhomogeneous fibrosis, which 
range from low-level diffuse fibrosis to dense fibrosis (also known as compact, scar 
or patchy). 
5.1.1. Patchy fibrosis 
Atrial fibrosis increases with age and disease, due to structural remodelling of the 
atrial tissue. The mechanism can be either myocardial cell death, increased 
deposition of collagen or reduction in collagen degradation. As the condition 
persists, collagen deposits become larger and more concentrated and can develop 
into dense patchy fibrosis.   
The areas of patchy fibrosis have been associated with AF arrythmogenisis52  and 
have been linked specifically to complex fractionated atrial electrograms 
(CFAE)141,49. CFAEs recorded in AF patients are characteristic of high frequency 
activation and slow conduction associated with AF.  CFAEs may reflect the 
complexity of the tissue substrate for persistent AF142. Thus, patchy fibrosis has 
been linked with slower and more continuous CFAEs141; clinically such CFAEs are 
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commonly used to predict favourable ablation sites in AF patients143,144. However, 
mechanistic links between highly variable electrogram morphologies and outcomes 
of CFAE-guided ablation procedures are unclear142,143. 
5.1.2. Border zones  
The effects of heterogeneous border zones (BZ) linked with compact fibrosis in the 
ventricles are well documented137.  Structural and electric remodelling in the 
ventricular infarct BZ after myocardial infarction has been shown to give rise to 
slow conduction, unidirectional block and re-entry. Remodelling factors include 
isolated strands of functional myocardium surrounded by dense fibrosis that 
provide conduction pathways within the infarct BZ50 and decreased lateral 
connections between myocytes due to altered gap junction distributions145. Both 
these factors reduce conduction velocity during infarct healing.  Image-based 
computer modelling has provided a powerful tool for investigating the mechanistic 
links between such structural anisotropy and electric activity in ventricular infarct 
BZ146. 
Recent studies141 have observed that areas adjacent to dense fibrosis in the atria 
have also shown high levels of arrhythmogenic activity. These myocardial areas, 
whilst still fibrotic, are not damaged sufficiently to fully inhibit wave propagation 
and have a high correlation to CFAEs141.  Such regions commonly surround dense 
fibrotic areas which have been shown to have low levels of electrical activity. A 
cause for this may be that they allow for re-entrant behaviour within the borders 
zone creating a circus movement around the dense fibrosis. These regions, 
characterised by both structural remodelling and abnormal electrical activity, are 
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similar to ventricular infarct BZ. Therefore, such regions of patchy fibrosis that have 
dense-to-diffuse fibrosis gradients are increasingly being referred to as "border 
zones" and linked with arrhythmogenic effects in the atria.  
5.1.3. Imaging of fibrosis 
Fibrosis is difficult to image using conventional clinical methods due to the limited 
resolution of imaging techniques approved for patients. Animal studies147–150 use 
ex-vivo histological dissection followed by collagen staining to quantify fibrosis. 
Some human studies have utilised post-mortem hearts151 or biopsy data136 from 
patients to histologically compare atrial regions with varied electrical activity. These 
methods are largely unsuitable for patients due to the invasiveness of the 
procedure. Furthermore, they are limited in coverage of the atria and only allow for 
small windows of observation on the atrial wall.   
While fibrosis can be clearly detected using histological staining, in-vivo imaging has 
inferior resolution, but is non-invasive and can cover the whole atria. An MRI-based 
method, LGE MRI, was originally developed to image myocardial infarction and 
focal scar but has emerged in the past 5 years as a means to quantify atrial fibrosis 
in-vivo. LGE relies on the injection of a Gd-based intravenous contrast agent, which 
alters the MR properties of the tissue where it is absorbed, reducing the tissue’s 
longitudinal relaxation time constant, T1. As Gd cannot enter healthy cells and the 
extracellular volume (ECV) is increased in fibrotic areas, Gd compounds tend to 
accumulate in regions where there is fibrosis. This allows the identification of 
fibrotic areas as atrial regions are brighter than healthy myocardial tissue in T1-
weighted MR images. The use of LGE MRI to detect atrial fibrosis in AF has been 
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pioneered by a the CARMA group in the University of Utah152, and applied to assist 
in ablation procedures8,139.  
LGE MRI gives the best clinical option for atrial wall composition analysis due to the 
low invasiveness and it is routinely performed on patients prior to the ablation 
procedure, to provide navigation images. The technique has been criticised, and it is 
notoriously difficult to get reproducible results on fibrosis segmentation from LGE 
MR images.153 The method is also limited to use on pre-ablation patients,140 as the 
intensity of the ablation lesions in the image can overwhelm any atrial fibrosis due 
to disease.  However this method offers us the only opportunity to study spatial 
distributions of fibrosis in the atria as well as easy access to patient data due to 
procedural non-invasiveness. 
5.2. Methods 
The following section outlines the changes made to the 3D atrial model (Chapter 4) 
to incorporate patient-specific distributions of patchy fibrosis and simulate its 
effects. It also includes the image processing pipeline that converts patient MRI 
data to useable datasets for the model.  
5.2.1. Late gadolinium enhanced MRI 
The images used in this study were obtained from 3 permanent AF patients 
recommended for routine, first time pre-ablation imaging. The data was 
randomised to ensure patient privacy. The scanner used was a Philips 3T MRI 
scanner and the images were obtained at 1.4x1.4x4mm3 resolution and saved in 
DICOM format.  Two MRI modalities were used; early Gd angiographic imaging 
(Figure 31D) and LGE MRI (Figure 31A-C). The angiography images were used for an 
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improved segmentation of LGE MRI data (see below). These were taken in the same 
cardiac phase.  
Figure 31. Patient-specific LGE MRI datasets. A-C show late Gd enhanced MRI slices through 
the atria (two atria are labelled in white) with areas of high intensity linked to fibrosis 
indicated by the black arrows. D shows a Gd angiographic image with high-intensity blood 
volume, which is used in the segmentation of the endocardial surface. C and D are from the 
same patient scan in the same coronal slice. The images were 3D MR scans acquired on a 
1.5T MR scanner. The white scale bar is 10mm. 
5.2.2. Image Processing Pipeline 
Initially, 3D distributions of atrial fibrosis were reconstructed using manual region 
based segmentation, to be later registered with the Visible Human atrial dataset. 
The accuracy of this method was limited and time consuming, as both location and 
size of the fibrotic regions are subject to operator error.  
A                                  B       
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For the fibrosis segmentation method to be more repeatable, an image processing 
pipeline was developed to reconstruct and register the LGE data with the 3D atria 
(Figure 32).  The Pipeline utilises fibrosis segmentation tools developed by the 
CARMA group at the University of Utah as plugins to 3D SlicerTM. This enables two 
different forms of fibrosis segmentation, either a binary dense patchy fibrosis or as 
continuous fibrosis as a function of image intensity. These methods are compared 
during this chapter.  
The extraction of fibrosis data from MR images requires thresholding of the 
intensity of the atrial wall. Obtaining the atrial wall in MRI data is non-trivial70 and 
detailed segmentation can only be done manually due to low resolution and SNR. 
This process is extremely time consuming and may still provide discrepancies 
between segmenters. This will be further discussed in the following chapter. 
Fortunately, the LGE MR images are acquired in the same session and at the same 
cardiac phase to an angiography image that is used as a navigation image for 
planning ablation procedures. The angiographic MRI images (Figure 31D) the blood 
pool which has a high intensity due to the contrast agent (Gd) and allows for 
accurate semi-automatic segmentation of the endocardial surface. This is achieved 
using a region growing algorithm within ITK-snap, which utilises seed points that 
iteratively dilate. The growth is limited by image intensity gradients. The segmented 
endocardial surface can then be dilated to provide an epicardial surface. In some 
cases it required manual rectification in highly convoluted areas. The dilation is 
usually between 3-5mm, which corresponds to the variable atrial wall thickness. 
112 
 
The endocardial volume is then subtracted from the dilated epicardial volume 
creating a 3D wall mask.70 
 
Figure 32. Diagram of the image processing pipeline used to obtain 3D distributions of atrial 
fibrosis and integrated them into 3D atrial models. It is broken down into blocks (in blue) 
showing the programs used.  
Utilising tools developed by the CARMA group, available as a 3D Slicer plugin 
(http://www.slicer.org/slicerWiki/index.php/Documentation/4.5/Modules/ScarVisu
alization), provides 2 different methods for fibrosis segmentation. The first, named 
“automatic scar segmentation”, uses a K-means clustering algorithm. This produces 
a binary fibrosis model in the masked region, identifying the densest fibrosis areas. 
The second method collects the MR intensity data from the masked image applying 
no threshold or segmentation. Both methods project the data onto a surface mesh 
of the endocardium.  
This 3D atrial mesh is then registered to a respective 3D mesh of the Visible Human 
Female atria using the IRTK-toolkit (https://biomedia.doc.ic.ac.uk/software/irtk/) 
using a non-linear deformation. The registered 3D atrial mesh is projected onto the 
Visible Human atrial dataset using a “nearest neighbour” algorithm. Fibrosis 
datasets obtained using the ‘threshold’ tool are segmented by LGE MRI threshold, 
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with the threshold values being defined on the range of the image intensity in the 
masked image.  
Figure 33. LGE MRI histograms.  A shows a comparison between healthy volunteers (black 
shading) and fibrotic (grey shading) tissue, from Benito et al.,154 note that this includes the 
blood pool. The fibrosis histogram clearly shows the skew associated with fibrosis. B shows 
a masked histogram, i.e. only the intensity of the voxels within the masked atrial wall 
region. The red lines show a range for fibrosis level segmentation. (1) is the lower limit of 
the diffuse fibrosis (levels 1-3) and 2 shows the lower limit for the dense fibrosis regions 
(levels 4 and 5). The dashed red line (3) shows the lower limit of the densest (level 5) fibrosis 
region. The red line denoted MI shows the maximum intensity from which the fibrosis 
regions were calculated.  
 It has been theorised that the myocardium and fibrosis in the atria could produce 
distinct MR intensity peaks. In reality there is significant overlap and they are 
indistinguishable in atrial MRI. Also there is a large variation in the intensity 
histograms between scans and therefore tissue cannot be explicitly quantified by 
intensity value. It is due to this that the range of intensity threshold values was 
determined uniquely for each patient. To estimate the fibrosis peak, an 
encompassing range of intensity values must be found. This was calculated 
individually for each patient using the maximum intensity (MI) as the upper limit 
(Figure 33B). The latter was the last significant intensity value, which was the last 
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histogram bin with a population greater than 1% of the maximum population (in a 
histogram with 50 bins over a range of 255).  
This enabled the removal of outliers, as some of the intensity histograms had a 
large range of high intensity values with very low voxel populations (<1%). The 
range was divided into 7, with the lowest 2/7th being allocated to healthy tissue 
and each fibrosis levels 1-5 as the following 1/7th of the range (moving towards the 
higher values). Due to the reduced populations in the densest fibrosis level (5), the 
last 1/7th of the range was expanded by 20% (moving towards the lower values). 
This provided the significant regions of dense fibrosis that can be observed in the 
MRI images. 
Figure 34. Reconstructed left atrium fibrosis distributions mapped onto the 3D human atrial 
model. Three methods are applied to the same patient dataset. A shows a fibrosis 
distribution created from 2D projection of the reconstructed 3D mesh to the Visible Female 
3D atrial volume. B shows a synthetic fibrosis gradient generated from the fibrosis 
distribution shown in A. C shows a full patient-specific fibrosis distribution with the gradient 
generated from thresholding the LGE MRI intensity.   
 
 
A                      B              C                           
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To investigate the role of threshold variation, two alternative segmentations were 
created for each LGE MRI dataset, one with a high and another with a low 
threshold. This was created by shifting (10 units of LGE MRI intensity) the threshold 
(Figure 37). 
The segmented fibrosis regions were considered to be transmurally uniform in the 
3D atrial model.  The developed image processing pipeline has the potential to 
accommodate non-uniform fibrosis throughout the wall, but this was not 
implemented due to the small thickness and the coarse image resolution. However, 
should the resolution limitations be improved in future imaging modalities, then 
the model could be applied with more accuracy.  
5.2.3. Fibrosis border zones 
Simulations of the border zones that reflect dense-to-diffuse fibrosis gradients were 
carried out in 2D atrial tissue (Figure 38) and in 3D atria (Figure 33C). In 2D tissue, 5 
concentric contours of increasingly mild fibrosis were created around a central 
dense fibrotic region. The contour number was then used as an index for applying 
fibrotic properties (see below). 
In the 3D atria 2 methods of BZ creation were applied. A synthetic BZ composed of 
5 concentric areas each 1-2 voxels thick was created, surrounding the binary 
fibrosis segmentation. These were created with a moving 3x3x3 ball filter for each 
level (Figure 33B). For each voxel of fibrosis, the surrounding voxels in the filter 
(that were not already occupied with fibrosis) were denoted as the next fibrosis 




Figure 35. Reconstruction of fibrosis by intensity threshold method from 3 patients. 
Variation in distribution can clearly be seen between patients A-C. A and C show cases with 
lower thresholds (see Figure 37) and B shows a case with a high level threshold. 
The second method is reliant on MRI image intensity to create the 5 fibrosis levels 
(Figure 34C). In most cases these had good concentricity around the densest central 
regions, but were overall, considerably less uniformly than the synthetic BZ.   
5.2.4. Computational 3D atria model 
The 3D atria model used was discussed in Chapter.4. It integrates human atrial 
geometry, fibre orientation, region-specific electrophysiology, ionic remodelling 
and a novel electrophysiologically detailed model for an atrial fibroblast and M-F 
coupling. In this section, the model included 5 distinctive fibrosis levels, indexed 1-5 
depending on the distance from the central dense fibrotic region (Figure 34B) or 
LGE MRI intensity (Figure 34C). Index 0 represents no fibrosis, and regions with 
indices 1-5 are modelled as increasingly severe diffuse-to-dense fibrosis: 
specifically, as indices 0-5 corresponded to progressively increasing M-F coupling (0-
5 fibroblasts per myocyte) and decreasing diffusive coupling between myocytes 
(100%-20% of the diffusion coefficients). 
A                     B         C                           
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Figure 36. Fibrosis distributions in different datasets. A shows differences in the fibrosis 
distribution between 3 patients and between varying intensity thresholds, and B shows the 
variation between segmentation techniques in one patient. The suffixes high and low refer 
to the relative threshold and syn to the synthetic BZ. 
The conditions used for the whole 3D atria in all simulations were high anisotropy 
and ionic remodelling (Chapter 4).  AF was initiated by fast LAA pacing in each of 3 
"persistent AF" atrial models with patient-specific distributions of fibrosis.  
5.3. Results 
5.3.1 Left atrial fibrosis distributions 
The segmentations of LGE MR Images yielded different fibrosis distributions in 3 AF 
patients. The fibrosis distributions observed varied in the extent and severity, as 
can be seen in Figure 36 and Figure 37. All datasets showed areas of more severe, 
dense fibrosis (based on increased LGE MRI intensity) in the posterior LA (Figure 
35), which is a common ablation target. 






















































































Figure 37. Atrial fibrosis distributions of 2 patients based on LGE MRI datasets with 
variation of the intensity threshold. The levels 1-5 describe fibrosis severity based on LGE 
MRI intensity. A and C show the fibrosis distributions for high threshold segmentation. B 
and D show the low threshold segmentation datasets. 
The relative quantised distributions of fibrosis in the thresholded datasets showed a 
higher distribution in the lower fibrosis levels (Figure 36). Significantly lower 
amounts of fibrosis were observed in the higher levels (4-5) despite a shifted bias 
for level 5 fibrosis. In these datasets good connectivity of fibrotic regions was 
observed, (i.e. no isolated small islets fibrosis) and the fibrosis levels are presented 
concentrically (Figure 35).   In contrast, the synthetic boundary showed a more 
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even distribution of fibrosis between the fibrosis levels and overall a much lower 
intensity. 
Figure 38. 2D simulation of atrial tissue with patchy fibrosis border zone. Activation times 
during one period of a re-entrant wave rotation around a fibrotic region are colour-coded 
using a rainbow palette. The dashed black lines show the inner and outer limits of the 
border-zone. The area labelled DF is dense fibrosis and signifies the area where fibrotic 
conditions are maximised with an 80% reduction in diffusion coefficient and 5 coupled 
fibroblasts. The white area shows inactivated tissue within the patchy fibrosis region. The 
white line indicate a wavefront at 100ms the black arrow indicates wave propagation 
direction. 
5.3.2 Simulations of fibrotic atria tissue 
In 2D tissue simulations, wave pinning to the patchy fibrosis border-zone was 
observed.  In less than 500ms after its initiation by cross field protocol, the re-
entrant spiral wave became pinned to the region of fibrosis within atrial tissue. The 
dense-to-patchy fibrosis gradient enabled slow conduction around the border 
(where the diffusive coupling was reduced), resulting in persistent re-entry around 




region was incompletely activated (Figure 38). This is due to slowing down of the 
wave conduction in deeper regions of the fibrotic region, with CV effectively 
dropping to zero in regions indexed 4-5. Without re-entry, the whole tissue 
including the dense fibrosis region was activated by a propagating plane wave. 
Figure 39. Stabilization of rotors in patchy fibrosis regions. A and B show two different 
patient-specific fibrosis distributions, and C and D show the respective single rotor period 
activation maps. The activation maps illustrate the variation of rotor pinning specific to the 
distributions of fibrosis. Wave propagation direction is denoted by the black arrow, the core 
of the rotor is indicated by the solid white shape and central dense fibrosis regions are 
indicated by the dotted white lines. C shows a rotor pinned directly to a dense fibrotic 
region. D shows a rotor with the core adjacent to a dense fibrotic region, but rotating within 
a border zone. 
A                                     B      
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In 3D atrial model simulations, short duration pinning to the fibrotic region was 
seen in most cases, both for different patients and for different methods of 
generation patient-specific fibrosis (Figures 39-41). Permanent rotor stabilisation in 
the border zone was seen in 2 cases, where rotor was pinned until the end of 
simulation. One of these simulations produced rotor movement directly around an 
area of dense fibrosis and another within an adjacent border zone of less severe 
patchy fibrosis (Figure 39).  In both case, the rotor core was within regions of 
broadly defined patchy fibrosis, characterised by severity indices between 3 and 5. 
Spatio-temporal dynamics of these rotors is illustrated in Figure 40.  
In patient-specific 3D atrial model simulations with variation of LGE MRI intensity 
threshold, different behaviours were observed (Figure 41). In simulations with the 
higher thresholds (lower fibrosis level) no stable rotor pinning was observed, with 
only short lived (less than 1 second) meandering re-entry in the LA fibrotic regions 




Figure 40. Spatio-temporal dynamics of rotors pinned to fibrotic regions. A.1-A.3 show the 
rotor progression with the fibrosis distribution shown in Figure 39.A and B.1-B.3 show the 
rotor progression with the fibrosis distribution, shown in Figure 39.B.  Snapshots showing 
the voltage distribution in the posterior LA are 30ms apart, and the rotor direction is 
indicated with the white arrows.  
Simulations of the same two patient-specific atrial models with the lower threshold 
(higher fibrosis level) showed severe wave breakdown, with multiple re-entrant 
wavelets in the left and to a lesser extent the right atria. The wavelets in the fibrotic 
region created complex interactions that prevented a single mother rotor to form 
(Figure 41B and D). The complex electrical activity in both 3D patient-specific atria 
was characteristic of AF and was sustained to the end of simulation (10 seconds). 
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Figure 41. Snapshots of re-entry in 3D atria with fibrosis distributions based on high and low 
thresholded LGE MRI intensity datasets. A and C show two patient cases with a high 
threshold (lower amount of fibrosis) and B and D show the respective cases with a low 
threshold (higher fibrosis). The rows delineate different patients (A,B and C,D). In the high 
threshold cases (A and C), only a short lived rotor (indicated) was present in the LA. In the 
high threshold cases (B and D), multiple re-entrant waves are present in the LA fibrotic 
regions. Black arrows show directions of wave propagation, white dashed lines indicate 
level 5 fibrosis. 
5.4. Discussion 
The 3D atrial simulations performed for this chapter indicate the importance of 
using patient-specific LGE MRI data to study AF. They also allude to the importance 
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of fibrosis in arrhythmogenesis due to the unique wave interactions for different 
fibrotic distributions. The developed image processing pipeline could also be useful 
for image-guided clinical interventions that are increasingly reliant on patient-
specific knowledge about fibrosis patterns. In future, linking patient fibrosis 
distributions and arrhythmogenesis could lead to bespoke and more accurate 
ablation techniques, with reduced procedure time and lower AF recurrence rates.   
5.4.1. Fibrosis segmentation 
Although the threshold segmentation method requires further validation, this work 
aims to investigate the effect of substantial fibrosis regions, which can be observed 
in MRI images. This method was based around the theory that the LGE MRI 
intensity histogram right skew was a quantification of fibrosis. This has been 
recently quantified with post ablation scar154. 
 The pipeline enabled the creation of unique non-binary fibrosis distributions for 
each patient. The reconstructed patient datasets showed increased fibrosis 
distribution on the LA posterior wall. This region is well known for its association 
with AF ablation, and may be statistically prone to fibrotic infiltration. However, it 
may also be due to partial volume averaging from the spinal connective tissues or 
descending aorta which have a high LGE MRI intensity (see Figure 31A and D). 
The lower extent of fibrosis on the roof and floor of the LA may be due to the lower 
Z axis resolution of the MRI scan.  Regardless of the limitations of the imaging 
method, LGE MRI intensity has been strongly linked to fibrosis, and the 
reconstructed fibrosis distributions agree with existing knowledge of fibrosis 
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distributions. Moreover, results of this work show the patient-specific variation of 
such distributions and their effects on the variable wave dynamics underlying AF. 
Two different methods of fibrosis segmentation were used in this work, (i) binary 
dense fibrosis segmentation with a synthetic BZ and (ii) thresholded LGE MRI 
intensity. Although the former relies on a more complex segmentation technique, 
there is a good spacial correlation between the locations of the dense fibrosis 
segmentations in cases (i) and (ii) (Figure 34). However, the shape and extent of the 
BZs of patchy fibrosis are significantly different. This may be due to the simplicity of 
the thresholding method or due to the UTAH segmentation method being applied 
slice by slice along the Z axis. Which account for the inherent variation of contrast 
in MRI slices. However the concentricity and connectivity of the fibrosis threshold 
levels segmentation, suggest that the fibrosis is less susceptible to contrast 
variation between layers.  
5.4.2. Simulations of patient specific fibrosis 
The 3D atrial model simulations showed a wide range of electrophysiological 
behaviours with different fibrosis datasets and distributions. In the simplest case, 
the fibrosis was originally mapped onto the 3D atria as a binary region of dense 
fibrosis (Figure 34A). Initial simulations where this region was set as either non-
conductive or with severely reduced conductivity did not produce any 
arrhythmogenic effects, with waves simply passing around the region. Only when a 




Stabilised rotor formation was observed in 2 simulations; one for a fibrosis 
distribution with synthetic BZ and one with LGE MRI intensity threshold. The former 
produced a larger circus movement around a dense fibrosis region (Figure 39 C) and 
the latter produced a smaller rotor adjacent to a dense region (Figure 39 D). In both 
these cases the simulation had high gradients of fibrosis density, which may be a 
mechanism for rotor stabilisation.  
In this research the simulations also show that patient specific fibrosis distributions 
can induce wave breakdown (Figure 41B and D) which is symptomatic of AF.  This 
was only observed in simulation of high levels of fibrosis (obtained with a low LGE 
MRI intensity threshold) and resulted in permanent AF for the duration of the 
simulation (10s). Smaller re-entrant wavelets were observed in these simulations 
moving chaotically throughout the fibrotic region. Contrarily, in simulations of 
lower levels of fibrosis in the same patient (obtained by using a higher LGE MRI 
intensity threshold) produced very short duration re-entry that was neither stable 
nor resulted in wave breakdown. Note that the cumulative amount of fibrosis was 
not very different between the high and low thresholds (Figure 36), rather, it was 
distributed more in fibrosis levels 3-5 with a lower threshold. The simulations show 
that the wave dynamics underlying AF should be determined by the amount of 
severe dense fibrosis (levels 3-5), rather than total size of fibrotic areas. 
5.4.3. Challenges of fibrosis imaging in the atria 
The difference between the high and low levels of fibrosis shows that the 
developed image processing and modelling pipeline is sensitive to the choice of 
parameters (such as LGE MRI intensity threshold) and can yield very different 
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results. Whilst there is little quantification available for LGE MRI intensity and 
amount of fibrosis from patients, the LGE MRI intensity should indicate higher areas 
of fibrosis136 in comparison to the rest of the tissue.  The LGE MR images may also 
suffer from partial volume averaging, in which neighbouring tissues influence the 
wall mask because of the coarse resolution of the image. This is particularly 
prevalent in regions where the distance between the atrium and the adjacent 
tissues is small or when adjacent tissues are particularly high intensity. For example 
descending aorta or spine. 
5.4.4. Conclusions 
It is clear from this work that inhomogeneous fibrosis distributions in the atria 
significantly affect the propagation of atrial waves in complex ways that are difficult 
to predict. It has been shown that a wide range of re-entrant behaviour between 
different patient specific distributions, from wavefront disruption and re-entry to 
multiple wavelet formation. The general trend was for waves to propagate closer to 
the inner denser areas of the patchy fibrosis region, reminiscent of electrical 
behaviour seen around the infarct border zones. However, the association of re-
entrant waves with the patchy fibrosis border zones in 3D atrial simulations was not 
absolute, indicating a potential role of other factors that can affect re-entrant 






6. Role of atrial wall thickness 
6.1. Introduction 
As discussed in previous chapters AF dynamics are highly variable between patients. 
This work has explored patient specificity in terms of disease state, i.e. fibrosis level, 
but for a more representative study, variation of other factors of atrial structure 
must be considered.  It is clear from anatomical studies that the atrial wall structure 
is highly heterogeneous and that intra-patient and intra-regional structural 
differences have distinct effects on the electrophysiological and mechanical 
function of the heart. Moreover, volumetric reconstructions of the atrial wall can be 
applied as the mask for fibrosis reconstructions, and hence greatly improve 
accuracy of the latter. Knowledge of the atrial wall variation from region to region 
(e.g., thicker LA to thinner PV) may provide a more personalised approach to 
catheter ablation in different patients and in different atrial regions (see below). 
However, the extent of knowledge of atrial wall thickness is sparse and is subject to 
large variation (Table 7). Thus, gaining insight into the role of atrial wall thickness 
and the extent of its variation in the atria are both important for better 
understanding AF and its treatment.  
6.1.1. Atrial wall thickness effects on ablation 
Ablation therapy is based on creating a functional block in the tissue by creating a 
non-conductive lesion. The lesion must transmurally penetrate the myocardium for 
conduction block to occur. Ablation therapy sufferers from high AF recurrence 
rates. This may be due to insufficient lesion penetration, preventing full isolation of 
arrhythmogenic regions. If the ablation energy is insufficient, inflammation at lesion 
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sites may be also responsible for temporary “false positive” isolation, as the tissue 
may be functional repaired.  Severe complications can occur, if excessive energy is 
applied during ablation, which include puncture155, PV stenosis156, tamponade, 
thrombosis or oesophageal ulceration157. The operator relies on estimates of 
energy required and success is measured by functional isolation, which may be a 
false positive. Further research is required to assess about the atrial wall thickness, 
whether that is patient specific or statistical, i.e. based upon patient categorisation.  
6.1.2. Wall thickness effects on electrophysiology 
Wall thickness also has a significant effect on atrial electrophysiology (as discussed 
in chapter 4). It is worth noting that these specific effects are related to structural 
changes in wall thickness rather than its dynamic changes due to the contraction. 
The latter does not change the electrotonic distance measured in space constants. 
Note also that the wall thickness is referred to in mm, rather than space constants. 
It has been hypothesised as a potential mechanism for arrhythmogenesis, with links 
being found between thickness gradients and stabilisation of rotors40,158. These 
parameters more thoroughly discussed in Chapter 4 and are based upon sink-
source relationships, where current is divided in positive thickness gradients. This 
has been shown recently by in theoretical studies of simple tissue slabs, where 
rotors show a tendency to move along high thickness gradient areas158.  However, 
these studies utilised simplistic tissue geometries and cell electrophysiology 
models, and have not considered realistic atrial shape and thickness variations. In 
studies with realistic, volumetric atrial geometries, patient specific wall thickness 
gradients are often overlooked. Recent models are moving towards a 
computationally efficient, but greatly simplified bilayer approach159 which does not 
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consider the atrial wall to be a continuum. However, patient studies provide 
increasing evidence for relationship of atrial wall thickness with CFAEs and 
therefore drivers for AF160,161. 
6.1.3. Wall thickness for fibrosis imaging 
A further advantage of accurate atrial wall thickness reconstruction is the potential 
for use of atrial wall segmentations as a volumetric mask in fibrosis imaging. The 
segmentation of fibrosis from LGE MRI is susceptible to over segmentation, as 
external structures such as the descending aorta can falsely identify fibrosis. A wall 
thickness mask could be used in these cases to avoid interference with non-atrial 
tissues. A statistical atlas of thickness could guide the dilation of the endocardial 
surface, in cases where the atrial wall cannot be directly imaged. 
6.1.4. Imaging wall thickness  
Research on atrial wall thickness is sparse and shows great variation of values, 
partially due to measurement inconsistency. Ex vivo anatomical studies on wall 
thickness have investigated the variation throughout the atria151,162–171. These 
studies only consider discrete sample-point thickness measurements, where wall 
thickness is measured using callipers in ex-vivo hearts. Additionally, these studies 
may not be representative of active tissue, as the wall thickness varies due to 
contraction and blood pressure, and ex-vivo tissue may not represent vivo 
myocardium. 
The same issue has hindered in-vivo imaging studies of the atrial wall thickness, as 
they also commonly utilise discrete sample points and do not measure wall 
thickness for the whole atria. Until now, these studies have all utilised computed 
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tomography157,160,161,172–177 which has a higher resolution than MRI but a low soft 
tissue contrast. Later in this chapter, we will demonstrate how novel MRI protocols 
can be applied to reconstruct the wall thickness non-invasively and with acceptable 
resolution in the entire atria.  
Imaging of atrial wall thickness is non-trivial. Unlike the ventricular wall which can 
be imaged with great success using conventional medical imaging modalities, the 
atrial wall is much thinner (1-5mm compared to 11mm), therefore any motion has a 
greater effect during image acquisition compared to the thicker ventricular wall. 
This causes problems for imaging methods with non-instantaneous acquisition such 
as MRI, as movement throughout the cardiac cycle ensures that the wall tissue does 
not continuously occupy the same voxels. Conventional atrial MRI considers the 
atria as a 2D surface which can be extracted from a contrast enhanced blood pool 
inside it. This is due to the low contrast between wall and lung preventing the 
extraction of the epicardial surface. There is also a partial volume effect with the 
low resolutions associated with MRI which further reduces the edge contrast and 
accuracy of the measurement. However the method offers significant advantages 
over other available methods; it is minimally invasive, it has good soft tissue 
contrast and is routinely applied to AF patients.  
6.1.5. Wall thickness measurement 
Atrial wall thickness has been previously studied as discreet points or regions rather 
than measuring a contiguous map. Reconstructing an entire 3D map offers a better 
insight into atrial electrophysiology but causes new image processing challenges.  
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Firstly segmentation is non-trivial due to the relatively low and variable contrast 
between the atrial wall, lung and blood. Most conventional methods of automatic 
and semi-automatic segmentation are not applicable. They cannot identify the 
inter-tissue borders continuously, and hence either over or under estimate the 
structure. Currently manual image segmentation, combined with automatic post-
processing, although labour intensive and time consuming, still offers the best 
accuracy for this application. 
The second issue is measurement of the wall thickness. The outcomes of such 
measurements can be very dependent of the algorithm used. If surface meshes of 
the endo- and epicardium are utilised rather than the 3D volumetric wall, 
measurements can be more easily performed. Studies measuring human cortical 
thicknesses using MRI have developed and used different automatic approaches for 
this. The highly convoluted nature of the cerebral cortex draws significant parallels 
to atrial wall, as simplistic measurement methods such as nearest-neighbour or 
surface normal are unsuitable, as structures can be missed.178  A study comparing 
several methods found that the most accurate measurements were provided by 
averaged nearest neighbour (from both inner and outer surfaces)178. This method 
also has the advantage of been relatively computationally inexpensive and easy to 
implement, and hence was used in the current study.  
The aims of this chapter were to investigate the inherent variation of the atrial wall 
thickness in both AF sufferers and healthy volunteers, and ascertain how these 
changes affect arrhythmogenesis. This was achieved by developing an image 
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processing pipeline converting atrial MRI data into 3D volumetric datasets for wall 
thickness measurements and related electrophysiology simulations. 
6.2. Methods 
This section describes the methodology for the development and analysis of the 
atrial wall thickness in patients and volunteers and how it can be used in 
computational modelling. The subjects for this work were 10 healthy volunteers 
(21-30years old, 3 female) and 3 pre-ablation patients (24-78 years old, 1 female) 
with persistent AF. 
6.2.1. Imaging protocols 
During the progression of this work a novel MRI protocol was developed in our 
group.70 Images were acquired in a para-axial plane using a black blood phase-
sensitive inverse recovery (PSIR) sequence with 1.4-mm isotropic resolution, but 
different cardiac triggering was applied for volunteers and patients.   
Movements of the heart during a cardiac cycle can impede imaging in high 
resolution. Therefore, the optimum timing is to acquire the image when wall 
movement in the atria is minimised. This occurs several times, at different cardiac 
phases. The longest period of constant atrial volume, which indicates minimal atrial 
motion, is between the passive and the active atrial emptying phase (booster 
pump) in late diastole. This was used for volunteers using the R-wave as a trigger. In 
AF patient scans, the images were acquired at maximum atrial volume, after 
completion of atrial filling and prior to the passive emptying phase. This enabled 
the images to be in kept phase with standard pre-ablation angiographic gadolinium 
images. The gadolinium angiographic images can be used to improve the wall 
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segmentation. Due to the earlier acquisition point in AF patients (compared to 
healthy volunteers) the R-wave was insufficient and a pulse oximeter was used as a 
trigger (Figure 42). 
 
Figure 42. Atrial MRI acquisition timing. The figure shows the LA volume the mitral valve 
velocity and the ECG during one full phase of the cardiac cycle. The blue line shows the 
image acquisition start for patients and the red for volunteers. The atrial phases of the 
atrium are indicated; the reservoir (filling) the conduit (passive emptying) and the booster 
pump (active emptying).  
In both subject groups respiratory gating, fat suppression and blood nulling were 
implemented to reduce cardiac motion and increase tissue contrast. To reduce scan 
time in patients the field of view was reduced and only the LA was investigated, 
whereas in volunteers both atria were imaged. An image quality rating was created 
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to qualitatively rate the likelihood of a successful segmentation. Images were rated 
on coverage and image quality, which accounted for Signal to Noise Ratio (SNR), 
blood-wall contrast and absence of artefacts. This value was essentially a 
segmentability measure showing the confidence in wall accuracy.  
6.2.2. Image segmentation methods 
For the images to be quantified, the atria must be segmented. Identification of the 
atrial wall is non-trivial. Even in successful images, only manual segmentation 
provided adequate results because of the low contrast and the variability of MRI 
intensity. The ratio of intensity between wall, lung and blood changes throughout 
the 3D image, making automatic segmentation difficult. Initial trials in automatic 
and semi-automatic segmentation were unsuccessfully implemented. This will be 
considered more thoroughly in future work.  
 
Figure 43. Flowchart of image processing pipeline. Blue areas indicate the program used for 
each stage of the pipeline. Square boxes indicate processes and rounded boxes indicate 
products.  
Manual segmentation was performed in ITK-SnapTM using a ‘paintbrush’ tool. Each 
atrium was segmented slice by slice coronally and corrected in second and third 
passes in sagittal and axial planes. The segmented atrial wall volume is used to 
136 
 
create a volumetric blood image of the atrium (corresponding to the volume 
enclosed by the endocardial surface). This is achieved using a region growing 
algorithm, built into ITK Snap. Points are seeded within the blood volume of the 
segmented atrial wall image. These iteratively dilate until the volume reaches the 
boundary of the atrial wall.  No smoothing is implemented to the blood volume at 
this stage and vessel openings are manually cropped to tidy up over-spill of the 
region growing algorithm.  
Some atrial structures were difficult to segment. In most images PVs were not 
included due to the difficulty in segmentation of their thin walls. PVs and atrial 
septa typically have thicknesses below 1.4mm and thus could not be accurately 
segmented. The atrial appendages were also difficult to segment due to the high 
density of pectinate muscles inside them.  
Variation between segmenters was investigated: 2 different datasets (both right 
and left atrium) were segmented twice and the differences were compared using a 
Dice score.  
6.2.3. Image post processing 
For thickness measurement, epi- and endocardial surface meshes need to be 
extracted from the volumetric data, which allows for extra-planar comparison 
between the two surfaces. Unless stated all post-processing was executed in 
MatlabTM. A flowchart of the image processing pipeline can be seen in Figure 43. 
The two segmented volumes (3D atrial wall and blood/endocardial volume) are first 
combined to make an epicardial surface; any holes (less than 1 voxel) in this volume 
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are filled using the Matlab function ‘imfill’. Meshes of the endo- and epicardial 
surfaces were then created with a marching cubes algorithm. The mesh quality was 
improved using mesh refinement and smoothing algorithms. For the volunteer 
datasets, the meshes were smoothed in MeshLab whereas patient cases were 
smoothed at the volume stage with a neighbourhood based smoothing algorithm 
and subsequent thresholding. This simplified the pipeline by reducing file format 
conversions between programs. 
6.2.4. Thickness measurement 
Various thickness measuring techniques were considered, with two being 
investigated in a simulated phantom (see appendix). This consisted of two 
concentric, yet offset, spheres which provide a controlled variation in thickness 
which could be calculated mathematically.  These were the snake method 179(a 
gradient vector flow variant) and the average nearest neighbour and were both 
simulated in Matlab. The former uses an energy minimising spline that iteratively 
deforms an endocardial mesh. The mesh is contained by an MRI contour of the 
epicardial surface. The deformed surface can be compared on a vertex by vertex 
basis to the original undeformed endocardial surface mesh (Figure 44A).  
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Figure 44. Atrial wall thickness measurement techniques. A. Shows the snake method, 
where the endocardial surface (S1, black line) is deformed in the image (blue volume) to 
create the epicardial surface (S2 black line). The amount of deformation (black arrows) for 
each vertex (red circles) is the thickness. B shows the averaged nearest neighbour method. 
Two surfaces are compared to find the nearest neighbour for each node. In cases where 
both epi- and endocardial nodes are the nearest neighbours of each other (A and C) the 
distance is the magnitude of the vector AC. For nodes that do not have mutual transmural 
nearest neighbours (i.e., B) an average of the nearest neighbour vectors is calculated for 
each node. For example the thickness at point B is calculated as (BD+EB)/2. 
As the mesh is deformed, a mathematical balance between curvature expansion 
and image intensity is maintained. This ensures that each vertex is evenly spaced 
rather than allowing points to preferentially congregate in thinner areas. The even 
spacing of the deformed mesh ensures irregular wall geometries are measured 
accurately.   
The average nearest neighbour method used an epi- and endocardial surface and 
for each voxel in both meshes finds a nearest neighbour on the opposite surface 
(see Figure 44B). In cases where nearest neighbours are mutual the distance 
between the vertices is the thickness. In vertices that are not mutual, nearest 




6.2.5. Atrial atlas building 
The atlas of the volunteer datasets was built using the same tools as used in 
Chapter 5. The atrial wall thickness meshes were non-linearly registered to a single 
atrial geometry using the IRTK-toolkit. The LA and RA were processed separately 
into 2 separate geometries.  
6.2.6. Image-based atrial simulations  
The 3D computational models used in Chapters 3-5 were implemented using the 
volunteer atrial geometry datasets. In order to purely investigate the effects of 
thickness and shape, the model was devoid of fibre orientation, regional 
heterogeneity and fibrosis. All parameters of the monodomain equation and its 
numeral solver were the same as the model described in Chapter 3, but utilising 
only the higher (longitudinal) diffusion coefficient value. In these simulations AF 
based ionic remodelling was implemented so that a stable rotor could be initiated. 
Which was achieved with cross-field protocol (Figure 8B). This was highly 
controlled, by holding the opposite side of the atria inactive until the rotor had 
stabilised, thus preventing additional rotor initiation and rotor meandering to the 
other side in the initial stages of the simulation.  
Due to the smaller space step required for the numerical integration of the 3D atrial 
model, the volunteer datasets were interpolated from 1.4mm to 0.3mm in Matlab. 
This had an additional beneficial effect of smoothing the “staircase” effect seen in 
the segmented volumes. The atria were simulated separately; this reduced the 
complexity of the wave dynamics and permitted rotor tracking.  
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For simplicity, rotor tracking was performing in pseudo 3D in Matlab, by projecting 
activation patterns onto a 2D plane. Subsequent voltage iso-lines of -30mV were 
compared and their intersection provided the rotor tip. The approach was semi-
automatic and required user guidance in order to verify the correct intersection.  
Figure 45. Segmentation of patient and volunteer MR images. A and C show a volunteer 
image without (A) and with (C) manual atrial segmentation. Green indicates the left atrium, 
red the right atrium and blue the atrial septum. B and D show a patient scan without (B) 
and with (D) manual atrial segmentation. In this instance the left atrium is indicated in red. 
White lines in the bottom right corner indicate a 1cm scale. Structures in A and B are 
annotated: DA and AA indicate the descending and ascending aorta, RV indicates right 
ventricle and SVC the superior vena cava. Scale bars are 10mm. 
A           B 
 
 












Preliminary simulations were performed in our group180 using a simplified cardiac 
electrophysiological model, the Fenton-Karma66 (FK). This showed rotor 
stabilisation in regions of highly heterogeneous wall thickness, particularly the rotor 
meandering occurred along the CT. In these simulations, rotors were sensitive to 
the proximity to structural heterogeneity, i.e. rotors that were ‘out-of-range’ did 
not react to the presence of wall thickness heterogeneities. This gives a good 
opportunity to compare the two models (FK used previously in our group and CRN 
used in this study) within the same geometry, and whether the structural 
properties have the same effects. 
6.3. Results 
6.3.1. Atrial MRI data acquisition  
The MR images seen in Figure 45 show a good contrast between the myocardium 
and the blood in both volunteers and patients.  However, there was still significant 
variation in contrast and SNR between subjects exemplified by the difference 
between Figure 45A and B. The success rate was highly dependent on patient heart 
and breathing rate. 
Segmentations for both patients and volunteers were performed on all datasets 
with a moderate or higher quality rating. Segmentation accuracy was reduced in 
highly convoluted atria due to the difficulty identifying adjacent regions 




The Dice coefficient estimated in each of the atria of two randomly chosen 
volunteers was 0.82 ± 0.06, ranging from 0.73 to 0.86. This shows a good 
agreement between atrial segmentations performed by different segmenters.  
Figure 46. Atrial wall thickness maps of two volunteers. A and C show the right atrium maps 
of the two volunteers and B and D show the corresponding left atria. Atrial structures are 
annotated, including the CT which can be observed as a significantly thicker region in the 
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6.3.2. Wall thickness in volunteers 
Each of the 10 volunteer MRI datasets was processed to produce a unique atrial 
wall thickness map (Figure 46). All maps showed regional variation of the atrial wall 
thickness, but the measured values were within bounds reported in the literature 
(Table 7).  
The mean thickness for volunteers was 2.4 ± 0.7 mm in the LA and 2.7 ± 0.7 mm in 
the RA. Between subjects the variation was less than 1mm. This is in good 
agreement with both literature measurements using computed tomography and 
ex-vivo anatomical dissection. Only in two instances are the results towards the 
upper limit, for the LIPV and the anterior LA.  
  
Figure 47. Atrial thickness map in the Visible Human Female dataset. A shows the RA and B 
focuses on the LA. The thicker CT and PM in the RA and the thinner PVs in the LA are seen 
clearly, similar to the reconstructions in Figures 4-5. 
Thickness variation in the reconstructed maps enabled the observation of different 
atrial structures, such as the CT which had larger thickness of 3.5-4.2mm 














(contributing to higher mean thickness in the RA), and the PVs which had a lower 
thickness of 1.5-2mm. 
A thickness map of the Visible Human Female dataset (which was used in the 
previous chapters) was also investigated. This compared well to the thicknesses 
obtained from volunteer MRI data, and had an average thickness of 2.7± 1.4mm. 
The volunteer datasets were non-linearly registered to produce a unique atlas of 
regionally averaged wall thicknesses in the entire atria (Figure 49). 
Figure 48. Left atrial wall thickness maps of two patients. A and C show posterior views of 
two different patient datasets and B and D show the corresponding top views for the same 
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6.3.3. Wall thickness in patients 
All of the 3 patient MRI datasets were also processed to produce left atrial wall 
thickness maps illustrated in Figure 48. The thin PV trunks were too difficult to 
accurately segment and were not included.  
One of the three subjects datasets does not include a LAA, which may be due to an 
abnormally small appendage or that it may have been out of view. The mean of the 
patient datasets wall thickness was higher than the average of volunteer datasets. 
However 3 datasets is not a significant enough sample to extrapolate a concrete 
relationship between patients and volunteers. This may be due to the presence of 
disease or because the data acquisition was in a different phase of cardiac cycle. 
The average LA value was 3.2mm +/-0.9mm, with the regional variations displayed 
in Table 7. 
 
Figure 49. The atrial wall thickness atlas for 10 volunteer datasets. A shows the RA and B 
focuses on the left. Note the thicker CT in the RA and the thinner PVs in the LA. 
 











6.3.4. Image-based 3D atrial simulations 
Simulations of the 3D atrial model based on the reconstructed volunteer RA 
geometry and CRN electrophysiology model with AF remodelling showed a stable 
rotor with significant meandering (Figure 50). The rotor tip tracking effectively 
monitored the rotor dynamics to explore how the multiple thickness transitions of 
the atria affect its meandering. Previous simulations with the FK kinetics produced 
neat ‘petals’ of a typical flower-pattern meander (Figure 50A), whereas new 
simulations with the remodelled CRN kinetics producing a much more extensive 
hyper-meander (Figure 50B). The rotor movement directions were also different, 
with the FK model producing rotor movement along the CT and the CRN to the 
thinnest part of the atria. 
Figure 50. Atrial activation map and rotor tracking maps. A shows an activation map of a 
rotor in the RA with the remodelled CRN model in a volunteer RA. The white arrow indicates 
the movement of the rotor core. B shows the corresponding rotor tracking pattern. C shows 
simulations in the same geometry but with the FK model performed previously by our 
group180. Notice the difference in rotor meander patterns (black lines) and direction 
(arrows) in relation to the wall thickness (palette below).   
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Areas of high thickness heterogeneity did not have the same effect in simulations 
with different ionic models. Note that previous studies have also reported 
conflicting hypothesis regarding the rotors movement near the thickness gradients, 
with the rotors pinned to the thick CT158, moving along the thickness gradient38 or 
moving down the gradient into the thinnest region.40 These results provide further 
evidence that rotor movement may be determined by a combination of geometry 
and ionic kinetics, such as the interplay between the relative extent of thickness 
gradients and rotor meander. 
6.4. Discussion 
This chapter presents the first reconstructions of atrial wall thickness maps 
obtained from black-blood PSIR MRI of 10 healthy volunteers and 3 patients with 
persistent AF.  Good agreement of wall thickness estimates with previous reports 
(Table 7) and with the 0.33mm resolution Visible Female atrial model suggests the 
MRI spatial resolution of 1.4mm did not introduce detectable systematic errors in 
the wall thickness measurement. These reconstructions were also used as proof-of-
concept for image-based 3D atrial simulations. 
6.4.1. Atrial wall imaging 
In terms of the image acquisition, there were significant differences between the 
patients and the volunteers. Primarily, the higher thickness values in patients may 
be explained by the fact that the images were acquired in different phases of 
cardiac cycle. In 2 patients, the images were acquired in atrial diastole and the atrial 
myocardium was minimally contracted. The higher thickness in patients may also be 
due to the pathology of their disorder or age related wall changes.  
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It should also be noted that in the patient scans, the LA volume was also 
maximised, which may stretch the wall longitudinally, thus changing the thickness 
compared to late atrial diastole (volunteers). 
6.4.2. Wall thickness measurement 
In terms of the wall thickness measurements, both methods considered performed 
well in the geometric phantom, but the average nearest neighbour methods was 
more efficient in atrial geometries. This was because the snake method was 
computationally expensive and proved too difficult to implement in complex atrial 
geometries. In regions of highly convoluted tissue structure, such as the 
appendages, the deformed mesh of the snake method became twisted and would 
not conform to the epicardial surface. 
The average nearest neighbour method has been shown to have good results in 
previous studies, specifically when used to measure cortical thicknesses in the 
brain.178 This research’s implementation was computationally inexpensive and 
provided the meshes were sufficiently dense, produced accurate wall thickness 
measurements.  
Atrial wall thicknesses and thickness variations for both volunteers and patients 
match those measured in literature for both imaging studies and ex-vivo anatomical 
studies. The regional variation shown in this study, matches the literature, with the 
PV (when segmented) having lower thickness and the CT having higher thickness. 
The wall thickness of these structures is critically important to understanding the 
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Table 7. Atrial wall thickness measured in volunteers, patients and literature. "Study" 
corresponds to the number of a respective reference in this chapter, "Vol" and "Pat" are 
volunteers and patients. T = Computed tomography, A = Ex-vivo anatomical studies, pAF= 




The imaging pipeline developed in this study can be used in AF patients and can be 
appended to existing MRI protocols to produce patient-specific atrial wall thickness 
maps. These are likely to be of particular interest for electro-anatomical mapping 
and ablation therapy in AF patients. The maps may offer a particularly useful tool 
for ablation, as knowing the atrial thickness variation can help make the choice of 
the appropriate RF power for creating fully transmural lesions, thus making the 
procedure safer and more effective.  
6.4.3. Simulations of wall thickness effects 
Knowledge of the atrial wall thickness may also lead to better understanding of 
atrial electrophysiological properties by establishing quantitative links between the 
atrial structure and function. The simulations performed in this chapter showed 
that rotor movement in the RA was sensitive to the wall thickness. Although highly 
heterogeneous, wall thickness did not have a stabilising effect on rotors, it did have 
conduction velocity slowing effects that can be seen in the rotor moving either 
along the thick CT (Figure 50A) or down the gradient into the thinner tissue (Figure 
50B).The difference may come from the increased extent and complexity of rotor 
meandering in the CRN model (applied in Figure 50B) compared to the simpler FK 
model (applied in Figure 50B). The FK model produces a smaller radius and more 
regular rotor meandering, which may make it more susceptible to sharp wall 
thickness gradients near the CT. The CRN model produces extensive hyper-
meandering and in these simulations, the rotor meanders from the thicker areas in 
the posterior wall of the RA to the lower RAA In this region conduction velocity is 
reduced due to significantly thinner atrial wall of the latter areas. These results 
show that the atrial wall thickness can have an effect on the rotor movement 
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additional to that due to patchy fibrosis. Future availability of PSIR and LGE MRI 
data from the same patient in future should enable detailed studies of the interplay 
between these two structural factors. 
6.4.4. Conclusion 
The current proof-of-concept computational work provides further evidence that 
atrial wall thickness can contribute significantly to arrhythmogenesis. Due to high 
inter-patient and inter-atrial heterogeneity, the effects of patient specific atrial 
structure must be considered when studying AF computationally. The current 3D 
atrial simulations were considerably less biophysically detailed than that described 
in previous chapters. This helps isolate the wall thickness effects from the effects of 
tissue anisotropy and ionic heterogeneity. Future studies will combine the detailed 
3D models of atrial heterogeneity and fibre orientation with patient-specific wall 
thickness and fibrosis distribution. Notably, the reconstructed atrial wall volumes 
can be directly applied as 3D masks for the identification and segmentation of 
fibrosis from patient LGE MRI scans. This opens new pathways to integrating 
various imaging modalities and computational approaches for the improved 







7. Conclusions  
This work set out to understand how fibrosis affects arrhythmogenesis in the atria. 
Due to the clinically observed correlation between AF progression and fibrosis 
deposition in the atria, an empirical link has been previously proposed. The aim of 
this work was to understand and substantiate this link with the aid of state-of-the-
art computational modelling and non-invasive imaging techniques. The 
computational investigation was multi-scale, building up from single atrial myocyte 
and fibroblast models to the 3D whole human atrial model. Medical imaging 
provided patient-specific atrial structural data and fibrosis distributions for the 3D 
atrial models, which enabled the investigation of inter-patient variation. The in-
silico nature of this work has the ability to study aspects of the disorder inaccessible 
to in-vivo analysis, such as mechanistic links between atrial fibrosis and arrhythmia.  
7.1. Main Findings 
The main findings of this work correspond with the structure of its chapters. As the 
models were developed and explored from single cell to 3D atria levels, different 
aspects of the problem were interpreted.  
1. Electrophysiological properties of atrial fibroblasts are significantly 
different from those of ventricular fibroblasts. A novel model of 
electrophysiology of a single atrial fibroblast (based on detailed 
experimental data by Wu et al.85) and its coupling to the atrial myocyte were 
developed. Atrial fibroblasts in the model had higher (more positive) resting 
potential compared to the previous models of ventricular fibroblasts 
(MacCannell et al.58), and therefore a stronger effect on the excitability of 
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atrial myocytes. Effects of M-F coupling with atrial fibroblasts on the APD 
were smaller than those of ventricular fibroblasts. The use of relevant 
electrophysiological data for the atrial fibroblast model make it more 
representative of atrial electrophysiology and better suited for the studies 
of atrial M-F coupling.  
2. The main effect of atrial M-F coupling is on the conduction velocity rather 
than the wavelength. M-F coupling with the developed atrial fibroblast 
model had a substantially smaller effect on the wavelength than either M-F 
coupling with the MacCannell et al. ventricular fibroblast model or ionic 
remodelling. However, stronger effect of coupling with atrial fibroblasts on 
the excitability of myocytes resulted in slower conduction in atrial tissue. 
This functional effect should contribute to the overall conduction slowing 
due to structural remodelling of fibrotic atrial tissue.  
3. The structural effects of fibrosis on atrial conduction are greater than the 
M-F coupling effects. In the developed 3D human atrial model, decreased 
M-M coupling and increased anisotropy of atrial tissue (both associated with 
interstitial collagen depositions due to fibrosis) had a far greater effect on 
atrial conduction than the electrophysiological effects associated with the 
M-F coupling. Hence, both functional effects of M-F coupling and structural 
effects of fibrosis contributed to arrhythmogenesis through the slowed 
conduction and generation of re-entry, but the structural effects played 
substantially more prominent role. 
4. Heterogeneous patchy fibrosis had a strong stabilising effect on atrial 
arrhythmogenesis. While progressive conduction slowing and increased 
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anisotropy resulted in the generation of increasing number of re-entrant 
circuits in the 3D atrial model. The addition of large areas of patchy fibrosis 
appeared to stabilise re-entrant rotors.  This was a common feature of a 
wide range of behaviours seen for different patient-specific distributions of 
fibrosis reconstructed from LGE MRI data. This provides a mechanistic 
explanation for AF stabilisation seen in chronic patients, and for recent 
successes in ablations around fibrotic areas.  
5. Atrial wall thickness is variable within the atria and between subjects and 
plays an important role in arrhythmogenesis. Novel MRI techniques 
enabled unique reconstructions of subject-specific atrial wall thickness 
maps. The data clearly highlights large thickness variations throughout the 
atria, providing means for the generation of a unique statistical atlas. This 
data was integrated into simple atrial models to demonstrate the role of 
wall thickness gradients in the atrial rotor dynamics.   
6. Patient-specific atrial structure and fibrosis distribution are critically 
important factors for arrhythmogenesis. Integration of patient-specific 
fibrosis distribution and atrial geometry into the 3D atrial model, enables 
simulations of vastly different forms of re-entry. The model provides means 
for systemising these scenarios and understanding the mechanistic links 
between patient variations of electrophysiological dysfunction and 
underlying atrial tissue substrate.  Novel pipelines for MRI processing and 
combination with 3D atrial models were developed in this study. They 
provided important tools for future patient-specific studies of AF and may 
provide useful tools for the guidance of clinical ablation procedures.  
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7.2. Future work 
The logical next step for the computational model development is to include more 
biophysical detail, for further model personalisation. In particular, the addition of 
personalised fibre orientation for patient geometry datasets, which could lead to a 
substantial improvement of the predictive power of the models. However, the 
existing imaging modalities cannot provide such information for a patient. Along 
with the current anatomical knowledge, future rule-based fibre orientation models 
should account for patient-specific atrial activation sequences.   Such methods are 
currently being developed at the Karlsruhe Institute of Technology.  
Another major limitation of the computational modelling in this work is the lack of 
comprehensive clinical validation. Myocyte electrophysiology has been extensively 
studied, with detailed experimental data available from ionic channel to myofibre 
levels for model validation. However only limited information is available when it 
comes to complex whole-atria electrophysiology.  Filling the gap in knowledge 
between in-vivo measurement of single cell dynamics and 3D atrial wave 
propagation will provide a challenge for future experimental studies. In the current 
study, such a gap is filled using image-based modelling. However to complete the 
validation, improvement of clinical electro-anatomical mapping, including better 
resolution on mapping catheters and whole atria-coverage, is required. It would 
provide a vastly better understanding of rotor dynamics, mechanisms of wave 
breakdown and when combined with atrial imaging, a better understanding of the 






Figure 51. Normal conduction in the patient specific fibrosis model. White dashed lines 
indicate the areas of dense fibrosis (level 4-5). This simulations shows wave front 
deformation in dense fibrosis region but the pacing frequency is not sufficient for re-entry.  
 
 
Figure 52. Atrial wall measurement methods. A shows the averaged nearest neighbour 
method, B shows the snake method and C shows the ground truth calculated 




M-F atrial fibroblast model 
The following is the Matlab script for generating the ionic current IGap from the 
atrial fibroblast.  
naiF =1.117e+01; 
nacF= 140.; 
kcF = 5.4;  
kiF =1.390e+02; 
gbnaF = 0.0006744375; 
GKURF=0.6;    






EnaF = 26.71*log(nacF/naiF)  ; 
EkF = 26.71*log(kcF/kiF)  ; 
  
insF = 0.018*vF;   % nonspecific current 
ik1F = 0.03*(vF+86.75)/(1+exp(0.05*(vF+20)));      
%modified ik1  
%to super impose with ins  
gkurF = GKURF*0.005+0.05/(1+exp(-(vF -15)/13.0));   
itoF = gtoF*oaF *oaF *oaF *oiF *(vF -EkF);  
ikurF = gkurF*uaF *uaF *uaF *uiF *(vF -EkF);  
%/*** Na background current ***/ 
ibnaF =9*gbnaF*(vF - EnaF); % increased back na %5x to get to 
resting potential of 47.68  
     inak_fibro = inak_fibro_max * (kc / (kc + 
kmk_binding_fibro))...  
        * (     sqrt(Nai_fibro*Nai_fibro*Nai_fibro)...  
        / ( sqrt(Nai_fibro*Nai_fibro*Nai_fibro)... 
        +   
sqrt(kmna_binding_fibro*kmna_binding_fibro*kmna_binding_fibro) 
))... 
        * ((vF - v_revF) / (vF - B_fibro)); 
  
    % update oa ito gate (dt in ms) */ 
vshift = -10; 
a = 0.65./(exp((vF -vshift+0.0)./-8.5)+exp((vF -vshift-
40.0)./-59.0)); 
b = 0.65./(2.5+exp((vF -vshift+72.0)./17.0)); 
tau = 15*1./(a+b);                              % 15*with 
added scalling factors to time constants x15 
inf = 1./(1+exp((vF -vshift+10.47)./-17.54));  
  
oaF = inf + (oaF -inf)*exp(-Tfac*dt/tau); 
% update oi ito gate */ 
vshift = -10; 
a = 1./(18.53+exp((vF -vshift+103.7)./10.95)); 
b = 1./(35.56+exp((vF -vshift-8.74)./-7.44)); 
tau = 15*1./(a+b);                               %15 with 
added scalling factors to time constants x15 
inf = 1./(1+exp((vF -vshift+33.1)./5.3)); 




% update ua ikur gate */ 
vshift = -10;%0; 
a = 0.65./(exp((vF-vshift+0.0)./-8.5)+exp((vF-vshift-40.0)./-
59.0 
b = 0.65./(2.5+exp((vF-vshift+72.00)./17.0)); 
tau = 1./(a+b);                                 % not scaled 
by 5 
inf = 1./(1+exp((vF-vshift+20.3)./-9.6)); 
uaF  = inf + (uaF -inf)*exp(-Tfac*dt/tau);  
% update ui ikur gate */ 
vshift = -10; 
a = 1./(21+exp((vF-vshift-195)./-28)); 
b = 1./(exp((vF-vshift-168)./-16)); 
tau = 5*1./(a+b);                                       
%5*with added scalling factors to time constants x5 
inf = 1./(1+exp((vF-vshift-109.45)./27.48));    
uiF  = inf + (uiF -inf)*exp(-Tfac*dt/tau);   
  
        %//total current across fibroblast 




I_gap = GgapF * (vF - V) / CmF;%=0; 
if COUPLING==0 
    I_gap=0; 
end 
vF = vF - dt * (itot_fibro + I_gap); 
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